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THE EFFECTIVENESS OF BEHAVIORAL ACTIVATION GROUP THERAPY:
TREATING COMORBID DEPRESSION ON A SPECIALIZED INPATIENT
POSTTRAUMATIC STRESS DISORDER UNIT
FOR COMBAT VETERANS
Theodore P. Wright, Ph.D.
Western Michigan University, 2002
The comorbidity of depression and PTSD has been shown to be relatively
prevalent. Researchers have found a 70% lifetime prevalence o f comorbid PTSD and
depression among combat veterans. This study examined the effectiveness of a
behavioral activation (BA) group treatment when administered to combat veterans
with comorbid depression and PTSD in the residential treatment program at the Battle
Creek Veteran Affairs Medical Center. Forty-five veterans participated in the study.
Twenty-four veterans participated in a BA treatment group while in the treatment
program. Twenty-one veterans attended the treatment program, but did not participate
in the BA treatment group and served as a comparison group. All o f the participants
completed a battery of assessments upon admission, at discharge, 1 month after
discharge, and 2 months after discharge. It was hypothesized that veterans
participating in the BA group would evidence a greater reduction in depressive and
PTSD symptoms than those in the comparison group at the posttreatment and two
follow-up assessments. Veterans in the BA group evidenced mild reductions of
depressive symptoms, but no changes in PTSD symptoms. The comparison group
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evidenced no reductions in depressive or PTSD symptoms. Factors associated with
changes in symptoms were also explored.
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CHAPTER I
INTRODUCTION
Prevalence
Depression is one of the most prevalent psychiatric disorders (Kessler et al.,
1994). Kessler and his colleagues completed a national study of psychiatric
comorbidity. The researchers assessed for the presence of psychiatric disorders using
Diagnostic and Statistical Manual o f M ental Disorders, Third Edition-Revised
(PSM-III-R, APA, 1987) criteria in 8,098 noninstitutionalized participants throughout
the 48 coterminous states. Both lifetime and 12-month prevalence rates were
gathered. After the initial surveys were completed, the researchers re-contacted
nonresponders and offered a financial incentive for participation. This second phase
allowed the authors to develop appropriate weights to estimate the presence of
psychiatric problems in individuals who continued to not respond.
The experience of a major depressive episode was the most prevalent specific
psychiatric disorder for both lifetime and 12-month rates. In the sample examined,
17.1% of the participants had experienced a major depressive episode in their lifetime.
The next most prevalent disorder was alcohol dependence, with a 14.1% lifetime
prevalence rate. Women tended to experience depressive episodes over their lifetime
at a higher rate than men (21.3% and 12.7%, respectively). During the 12 months
preceding the answering of the survey by participants, 10.3% of the sample had
I
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experienced a major depressive episode, with 12.9% of the women and 7.7% of the
men meeting diagnostic criteria within the last year. The next most prevalent disorder
was simple phobia, with an 8.8% 12-month prevalence rate.
Kessler and his colleagues (Kessler, Sonnega, Bromet, Hughes, & Nelson,
1995) completed a second study that assessed for the presence of “secondary
diagnoses” in a subsample of the 8,098 subjects who completed the original National
Comorbidity Survey (Kessler et al., 1994). Participants consisted o f5,877 people
throughout the country. Kessler et al. (1995) found that 7.8% of the subjects met
DSM -III-R diagnostic criteria for posttraumatic stress disorder (PTSD) at some point
during their lifetime. Women were found to experience PTSD more than twice as
often as men over their lifetime, 10.4% and 5%, respectively.
Trauma experiences most often associated with the development of PTSD
symptoms for women included rape and molestation, together accounting for 49% of
the women diagnosed with PTSD. For men, combat exposure and witnessing
someone being badly injured or killed were most commonly associated with the
development of PTSD symptoms. While only 6.4% of the sample had exposure to
combat, 38.8% of these individuals met diagnostic criteria for PTSD at some point in
their lifetime.
Comorbidity
An important issue that arises when diagnosing individuals is the comorbidity
o f psychiatric disorders experienced by individuals. Comorbidity is the presence of
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two or more concurrent psychiatric disorders. Comorbidity is an issue because the
presence of concurrent multiple diagnosable disorders has been associated with
greater distress and life dysfunction (Blanchard, Buckley, Hickling, & Taylor, 1998;
Shalev et al., 1998; Southwick, Yehuda, & Giller, 1991).
Kessler et al. (1994) found that 79% of the respondents in their study who
met diagnostic criteria for one disorder also had a diagnosable comorbid condition
during their lifetime. These findings provide researchers with the challenges of
identifying highly comorbid diagnoses, developing theoretical explanation for the high
co-occurrence, and designing treatments that address the complex problems
experienced by these individuals.
Research results have indicated that a significant proportion o f those
individuals who meet diagnostic criteria for posttraumatic stress disorder also meet
diagnostic criteria for major depression (Kessler et al., 199S; Orsillo et al., 1996).
Kessler et al. (199S) found that 47.9% of the men and 48.5% of the women surveyed
who met diagnostic criteria for PTSD had also met diagnostic criteria for
experiencing a major depressive episode. No other comorbid diagnosis with PTSD
was found to be more prevalent among the female subjects and only alcohol
abuse/dependence was found to be more prevalent (51.9%) than major depression
among the male subjects.
Orsillo et al. (1996) examined the comorbidity of psychiatric disorders and
PTSD among veterans who had been in a war zone. The authors found that, among
veterans with a history of combat experience who were diagnosed with PTSD, 70%
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had also met diagnostic criteria for major depression at some point in their lives. This
lifetime prevalence rate of comorbidity between PTSD and depression was second to
the rate o f comorbidity between PTSD and alcohol abuse/dependence in this same
population (77%). When these authors examined the rate of comorbidity of PTSD
with other psychiatric disorders present at the time of the assessment, major
depression was the most prevalent single diagnosis (S5%) followed by panic disorder
(25%) and alcohol abuse/dependence (18%). An important additional finding from
this study was that both the lifetime prevalence and “current” rates of major
depression were significantly higher among the veterans with PTSD than among the
comparison group of combat veterans who did not meet criteria for PTSD. However,
a significant difference was not found between the PTSD and non-PTSD groups in
either lifetime prevalence or “current” rates of alcohol abuse/dependence.
Depression and PTSD Diagnoses
Current Diagnostic Criteria for Depression
The Diagnostic and Statistical M anual o f M ental Disorders, Fourth Edition
(DSM-IV, APA, 1994) provides the current criteria for diagnosing psychiatric
disorders. For a person to be diagnosed with major depression, he or she must have at
least five o f nine different symptoms. Symptoms associated with depression include
depressed mood nearly eveiy day, diminished interest or pleasure in most activities,
changes in weight gain or appetite, sleep disturbances, psychomotor agitation or
retardation, loss of energy of fatigue, feelings of worthlessness or excessive guilt,
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problems with concentration or decision making, and suicidal ideation or intent. These
symptoms must cause impairment in functioning and cannot be caused by
physiological problems, substance use, bereavement, or psychosis. There also cannot
be a history of a manic, hypomanic, or mixed manic-depressive episode.
Current Diagnostic Criteria for PTSD
For a person to be diagnosed with PTSD with the DSM-W, he or she must
have been exposed to a traumatic event in which there was the occurrence or threat of
harm to the person or someone else and the person experienced intense fear,
helplessness, or horror. The person must report at least one symptom of reexperiencing of the trauma. Re-experiencing symptoms include unwanted
recollections of the event, recurring disturbing dreams of the event, acting or feeling
as if the event was recurring, psychological reactivity to external or internal cues
related to the event, and physiological reactivity to external or internal cues related to
the event. The person must experience at least three symptoms of avoidance or
numbing. Avoidance and numbing symptoms include attempts to avoid thoughts or
feelings associated with the event; attempts to avoid people, places, or activities
associate with the event; trouble remembering specific parts of the event; decreased
interest or participation in important activities; feeling detached or estranged;
restricted range o f affect; and negative view or no view of the future. The person
must experience at least two symptoms of increased arousal. Symptoms of increased
arousal include sleep problems, irritability or anger, problems concentrating,
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hypervigilance, and exaggerated startle response. In order to be diagnosed with
PTSD, the person must also report that these symptoms impair functioning and have
lasted at least a month.
Shared Symptoms Between PTSD and Depression
An important consideration in examining the comorbidity of PTSD and
depression is the overlap in symptoms required to meet each o f the diagnoses. Of the
17 symptom clusters used to diagnose PTSD and 9 symptom clusters used to
diagnose a major depressive episode in the DSM -IV(APA, 1994), 3 symptoms are
similar. These symptoms include sleep problems, difficulty concentrating, and
anhedonia. It may be argued that the overlap of symptoms between the disorders
would create a tendency for comorbidity and, to the extreme, indicates that the
disorders may be a unitary response to trauma rather than two separate identifiable
response sets.
Blanchard et al. (1998) explored these potential hypotheses with subjects who
had experienced motor vehicle accidents. The authors found that two independent,
but correlated, conditions were identified in the analysis. Another finding was that
there was no significant difference in the number of subjects meeting diagnostic
criteria for major depression if the symptom threshold was decreased from 9 to 6
depressive symptoms.
Blanchard and his colleagues also noted that those who met both diagnoses
were more subjectively distressed and socially dysfunctional than those who only met
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diagnosis for PTSD. Another group of researchers (Southwick et al., 1991) had also
found that subjects with comorbid PTSD and depression evidenced symptoms related
to personal distress, suicide, and social dysfunction. These researchers indicated that
combat veterans with PTSD and depressive symptoms tended to report a higher level
of self-criticism and guilt than subjects without this comorbidity.
Treatment
PTSD Treatment
Researchers have completed many studies examining the effectiveness of
treatments for PTSD (Foa, Keane, & Friedman, 2000). One population of subjects
that has received special attention in the PTSD treatment research has been combat
veterans (Rosenheck, Fontana, & Errera, 1997; Scurfield, 1993; Shalev, 1997).
Treatments studied for combat-related PTSD have included eye movement
desensitization and reprocessing (EMDR) (Carlson, Chemtob, Rusnak, & Hedlund,
1996; Devilly, Spence, & Rapee, 1998; Rogers et al., 1999; Silver, Brooks, &
Obenchain, 1995; Young, 1995), behavioral family therapy (Glynn et al., 1995),
implosive therapy (Keane, Fairbank, Caddell, & Zimering, 1989), anxiety
management training (Pantalon & Motta, 1998), relaxation (Silver et al., 1995;
Watson, Tuorila, Vickers, Gearhart, & Mendez, 1997), exposure (Rogers et al., 1999;
Rothbaum et al., 1999), and biofeedback (Silver et al., 1995). The effectiveness of
these different treatment approaches has been mixed, but has usually been very
modest.
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Inpatient multimodal programs which combine individual treatment
approaches have been used extensively with combat veterans with PTSD (Creamer,
Morris, Biddle, & Elliott, 1999; Fontana & Rosenheck, 1997; Hammarberg & Silver,
1994; Hutzell et al., 1997; Johnson, Lubin, James, & Hale, 1997; Johnson et al.,
1996; Ragsdale, Cox, Finn, & Eisler, 1996; Richards, Lovell, & Marks, 1994; Ru^ek
et al., 2001). Most of these programs have been Specialized Inpatient PTSD Units
(SIPUs) in Department o f Veteran Affairs Medical Centers (VAMCs) (Courtois &
Bloom, 2000; Rosenheck et al., 1997). Research has shown limited effectiveness of
these programs in reducing PTSD symptoms (Fontana & Rosenheck, 1997; Johnson
et al., 1996; Ruzek et al., 2001; Shalev, 1997). Some possible explanations for the
lack of treatment response is the chronicity of the problem (Johnson et al., 1999;
Johnson et al., 1996; Ruzek et al., 2001), comorbidity with other psychiatric disorders
(Courtois & Bloom, 2000), treatment resistance (Shalev, 1997), secondary gain issues
(Johnson et al., 1996), or an increase in affective symptoms in response to eliciting
trauma memories (Johnson et al., 1996; Ruzek et al., 2001). Foa et al. (2000) caution
about making premature conclusions regarding factors associated with reduced
treatment response. Foa and her colleagues suggest that researchers have not
systematically studied these factors, so no evidence exists to support the role o f any
specific factors.
Two recent movements in the inpatient treatment of combat-related PTSD has
been to reduce the length of the treatment (Fontana & Rosenheck, 1997; Johnson et
al., 1996; Ragsdale et al., 1996; Rosenheck et al., 1997) and to change the focus of
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treatment (Hutzell et al., 1997; Johnson, Feldman, Southwick, & Chamey, 1994;
Johnson & Lubin, 1997; Johnson et al., 1997; Johnson et al., 1996). Reduction in
treatment length has been supported by researcher findings of reductions in PTSD
symptoms with shorter inpatient stays that equal, or are greater than, reductions in
symptoms with longer inpatient stays. For example, Fontana and Rosenheck (1997)
found that veterans completing an average o f 37 days in treatment evidenced
reduction in symptoms equal to veterans completing an average of 100 days in
treatment. These researchers also found that the veterans in the shorter programs
tended to sustain improvements while the veterans in the longer programs tended to
show deterioration back to pretreatment symptoms levels over 12 months.
Other researchers (Hutzell et al., 1997; Johnson et al., 1994) have suggested
that programs begin to focus less on specific symptoms of PTSD and more on
reintegrating veterans into society. The researchers refer to programs that focus on
attempts to reduce core PTSD symptoms as “first generation” programs and
programs that focus on helping veterans reintegrate into society, work, and family as
“second generation” programs. Johnson and Lubin (1997) found that veterans rated
interventions characteristic of first generation programs more helpful than
interventions characteristic of second generation programs immediately after
treatment. However, these ratings reversed by the 12-month follow-up assessments.
In another study, Johnson and his colleagues (Johnson et al., 1997) examined the
relative effectiveness of treatment components with external focus, that were action
oriented, and had little Vietnam content (second generation) and components with
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more internal focus, that were verbal oriented, and had high Vietnam content (first
generation). The researchers found that the second generation components produced
greater improvement than first generation components.
Depression Treatment
With research findings indicating that combat veterans diagnosed with PTSD
are also at a high risk of developing major depressive symptoms (Davidson, Kudler,
Saunders, & Smith, 1990; Fairbank, Keane, & Malloy, 1983; Kessler et al., 199S;
Orsillo et al., 1996; Southwick et al., 1991), the need to include treatment
components for depression in conjunction with the treatments aimed at reducing
symptoms related to PTSD in multimodel programs becomes important. Two types of
interventions that have shown the most promise in treating depression are medication
and psychological treatments (Dobson, 1989; Hollon et al., 1992; Jacobson & Hollon,
1996). Tricyclic antidepressants, monoamine oxidase inhibitors (MAOIs), second
generation heterocyclics, and selective serotonin reuptake inhibitors (SSRIs) have all
been used to treat depression with varying degrees of success (Rehm & Tyndall,
1993).
Some of the most common psychological treatments used to treat depression
are cognitive-behavioral therapies (CBT) (Dobson & Block, 1988). Research results
have supported the use o f CBT for depression (DeRubeis & Freeley, 1990; Dobson,
1989; Fuchs & Rehm, 1977; Hollon et al., 1992; Jacobson et al., 1996; Sacco &
Beck, 199S; Shaw, 1977). The possible additive effect of using medication and CBT
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concurrently has also been examined (DeRubeis, Gelfand, Tang, & Simons, 1999;
Hollon et al., 1992; Hollon, Shelton, & Loosen, 1991; Jacobson & Hollon, 1996).
Results indicated that the medications and CBT are generally equivalent in reducing
symptoms of depression. The relative efficacy of the two interventions individually
and of the interventions combined continues to be debated (DeRubeis et al., 1999;
Elkin et al., 1989; Hollon et al., 1992; Jacobson & Hollon, 1996).
Despite the ongoing debate regarding the superiority of the two treatments,
CBT has been shown to significantly reduce symptoms related to depression across
several studies (Dobson, 1989). CBT is a treatment approach designed to change a
person’s immediate thinking patterns, behaviors, and beliefs (Addis & Jacobson,
1996; Beck, Rush, Shaw, & Emery, 1979). The therapy is structured and includes
progressively changing overt behavior, modifying problematic thinking, and
challenging and modifying a client’s belief system or cognitive schema (Jacobson et
al., 1996).
Dobson (1989) completed a meta-analysis examining the effectiveness of CBT
in the treatment of depression across 28 separate studies. Dobson found that CBT
was more effective than pharmacotherapy, behavior therapy, and no treatment.
Results indicated that subjects receiving CBT evidenced fewer symptoms
posttreatment, as measured by the Beck Depression Inventory, than 98% of the
subjects receiving no treatment, 67% of the subjects receiving behavioral treatments,
and 70% of the subjects receiving medication. Dobson also found that the
effectiveness of cognitive therapy was not related to the length of treatment, with an
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average length o f treatment in the studies of 14.9 weeks (SD = 9.5). Dobson indicated
that continued research was necessary to identify the components of the CBT
package that may be associated with the changes in depression level. He noted that
most o f the change in therapy often occurs early in the treatment package, when the
emphasis of the therapy is on increasing a subject’s behaviors.
The Development of the Behavioral Activation Treatment
Dismantling Cognitive-Behavioral Therapy
Jacobson and his colleagues (Jacobson et al., 1996) identified three
components within the CBT package that could be examined independently and that
may account for some, if not all, of the change associated with treatment efficacy. The
three components included interventions aimed at modifying clients’ cognitive
structures and processes, interventions designed to increase clients’ activity levels,
and interventions developed to teach clients how to cope cognitively with negative
life events and related thoughts. These authors also discussed possible theoretical
explanations for how each o f these components may be related to the reduction of
depressive symptoms.
Generally, cognitive theory hypothesizes that clients become depressed
because of problematic cognitive structures or core schema (Beck et al., 1979;
Jacobson et al., 1996; Sacco & Beck, 1995). These dysfunctional structures are
identified through overt and internal behavior, including verbal behavior. The goal in
cognitive therapy is to identify and effect change in the client’s core cognitive schema.
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By modifying these structures, it is hypothesized that thought processes and behaviors
will change and lead to more functional and adaptive ways of approaching life.
Jacobson et al. (1996) provided theoretical hypotheses related to the possible
mechanisms of change associated with increasing a client’s activity level and
modifying cognitive coping skills. It is hypothesized that by increasing behavior
activity level, clients increase the sources of reinforcement available to them in their
lives. With little activity, the client receives limited reinforcement in his or her life,
which leads to further decreased activity, which results in even less exposure to
reinforcing events, and results in increased depression. By changing a client’s
cognitive coping skills in conjunction with increasing activity level, it is hypothesized
that the client will be able to better manage personal cognitive reactions to Ufe events
as they occur while increasing the reinforcement he or she is experiencing in his or her
life. The constant practice of these new coping skills leads to the replacement of
negative interpretations of life events with more positive ones, which results in
decreased symptoms of depression.
Lejuez, Hopko, LePage, Hopko, and McNiel (2001) suggested that, in
conjunction with needing to increase reinforcement in a person’s life, there may be an
additional explanation for depression associated with a person’s activity level. These
authors suggest that depressive symptoms may also be associated with depressed
behaviors producing more immediate negative reinforcement than nondepressed
behaviors. The authors indicate that developing “contrived” reinforcers for
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nondepressed behaviors, until the behaviors themselves produce reinforcing effects,
may be important.
Jacobson et al. (1996) designed a study to examine the relative efficacy of
interventions designed to address each of these areas. The authors assigned 150
subjects to receive either the foil CBT, the behavioral activation (BA) components of
CBT, or the combination of the BA components and psychoeducation related to
modifying automatic thoughts. The authors found that each of the different treatment
modalities were equivalent in reducing symptoms related to depression. The authors
indicated that these findings support the use of BA for the treatment of depression
due to its relative brevity and simplicity when compared to the foil cognitivebehavioral treatment protocol.
Behavioral Activation Treatment
The BA treatment procedure used by Jacobson and his colleagues involved
identifying problematic behaviors specific to the individual client and using
interventions designed to increase the client’s activity level in his or her natural
environment (Jacobson, 1997). The authors included specific interventions believed to
achieve these desired results which include: monitoring daily activities, assessing
pleasure and mastery over activities, increasing difficulty level of activities to facilitate
feeling pleasure and mastery, cognitively rehearsing activities individuals are
scheduled to complete, identifying and solving problems as they arise using behavioral
principles, and teaching social skills.
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Lejuez et al. (2001) developed a BA treatment consistent with the Jacobson
(1997) treatment and explored the effectiveness of the BA treatment in reducing
symptoms o f depression in three case studies. The subjects attended 9, 10, and 12
individual sessions, which focused on increasing activity level, increasing pleasant
activities, and decreasing overt and covert behavior associated with depression. Each
of the subjects evidenced statistically and clinically significant reductions in scores on
the Beck Depression Inventory and increased subjective ratings of life functioning.
Porter (2000) developed a group treatment based on the Jacobson BA
treatment manual and examined the effectiveness of the intervention with outpatient
depressed clients being seen in community mental health centers. The researchers
reported positive results, with significant reductions in depressive symptoms across
assessment sessions. The results of this study raised at least two questions that could
be addressed in further research. First, how effective would the treatment be in an
inpatient setting? Second, would the treatment benefit individuals struggling with
multiple psychiatric disorders?
Future Research
Given past research results (Jacobson et al., 1996; Lejuez et al., 2001; Porter,
2000) and current trends in treating combat-related PTSD (Hutzell et al., 1997;
Johnson et al., 1994), the inclusion of a BA component in an inpatient treatment
program specializing in the treatment of PTSD may provide addition benefits to
patients suffering from comorbid PTSD and depression while answering some of the
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questions raised by the Porter study. The flexibility, brevity, and simplicity o f the
behavioral activation procedure makes it amenable to being incorporated into a pre
existing inpatient treatment program, such as the specialized inpatient PTSD Unit
(SIPU) at the Battle Creek Veteran Affairs Medical Center (BCVAMC).
The Battle Creek VAMC SIPU
The Battle Creek VAMC SIPU is composed o f three different treatment
groups, generally associated with a veteran’s history o f previous PTSD treatment and
a veteran’s subjective ability to confront progressively more intense treatment
processes. The three groups are described as “tracks” and include the “choices” track
(C-track) which lasts 22 days, the “rehabilitation” track (R-track) which lasts 28 days,
and the “stress recovery” track (S-track) which lasts 56 days. Veterans attending the
R- and S-tracks are admitted and discharged at the same time, creating treatment
cohorts. The C-track group members are admitted and discharged at different times,
creating a fluid group membership with constant member turnover.
Generally, veterans attend the groups sequentially from the C- to the R- to the
S-track. The different tracks are housed in the same area and interact socially. They
also attend many psychoeducational groups together. The primary difference in
treatment is a specific therapeutic group that meets up to three times a week and is
only attended by members of the specific cohort. This treatment group focuses on
progressively more trauma-specific material from the C- to the S-track. The S-track
group is devoted to discussing the veterans’ experiences before, during, and after
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their military experience, with primary emphasis on lifetime traumatic experiences.
Although there are scattered examples of the use o f various components of CBT in
the inpatient program, there is not a treatment modality currently in place that
specifically targets the treatment of depression. The program uses both first and
second generation treatment components. The C-track tends to focus more on second
generation interventions, while the R- and S-tracks tend to focus more on first
generation interventions.
The treatment program is voluntary and has a waiting list of veterans who
wish to attend. Before a veteran is admitted, he must complete a screening session to
assess whether the he is likely and able to benefit from the treatment offered at the
SIPU. Clinical and social work staff complete these screenings and make
recommendations for inclusion in or exclusion from the program.
Veterans are considered appropriate if they have verifiable combat exposure,
indicate the presence o f the symptoms necessary to be diagnosed with PTSD, and are
judged as competent by VA standards. Veterans are considered inappropriate for the
program if they are unable to intellectually comprehend the information discussed in
the program, are physically unable to participate in activities required for the program,
are actively suicidal, are actively psychotic, or are actively using alcohol or drugs.
Veterans are sometimes discharged before completing the program due to
behavior that is considered inappropriate or dangerous. A veteran may be asked to
leave by the treatment team if he has attempted or threatened, physically or verbally,
to harm a staff person or another patient. A veteran is also asked to leave if he tests
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positive for alcohol or drug use during his admission. Veterans who indicate the
presence of suicidal intent or show active signs of psychosis are transferred to the
acute psychiatric ward at the hospital for appropriate treatment. A veteran may also
be transferred to the acute psychiatric ward if he becomes physically assaultive.
The Present Study
The present study utilized a group treatment approach designed to fit within
the pre-existing voluntary residential treatment program for combat veterans with
PTSD at the BCVAMC. The R-track included a stay of enough time and a cohort
component necessary to institute a group process related to addressing depressive
symptoms. The study examined whether the inclusion of a BA group treatment for
depression was associated with additional benefit to the veterans, in terms of reducing
depressive symptoms. It was hypothesized that veterans receiving the BA treatment
would report a reduction in depressive symptoms and that this reduction would be
greater than the reduction in depressive symptoms reported by veterans receiving only
the standard inpatient treatment. It was hypothesized that the treatment would
facilitate further reduction in PTSD-related symptoms in this population beyond those
realized by participants only receiving the standard treatment. Potential factors
hypothesized to be associated with changes in the symptoms were also examined.
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CHAPTER II
METHODS
The Design
A 2 x 4 mixed-groups quasi-experimentai design was used for this study. The
between subjects variable was group assignment. Veterans received either the
standard treatment plus BA therapy group (BA group) or the standard treatment only
(comparison group). The repeated measure was assessment time, with data being
collected shortly after admission into the Specialized Inpatient PTSD Unit (SIPU)
(pretreatment), within a week prior to discharge (posttreatment), 1 month after
discharge (1-month follow-up), and 2 months after discharge (2-month follow-up).
Entire group cohorts were randomly selected to either receive the standard treatment
plus BA group therapy or standard treatment only. Seven separate cohorts were
included in the study. Three of the cohorts received the BA treatment. Four of the
cohorts served as the comparison group.
Participants
Participants in this study were veterans who had been accepted into the
“Rehabilitation Track” of the SIPU at the Battle Creek VAMC (see Appendices A
and B for Western Michigan University Human Subjects Institutional Review Board
and Battle Creek VAMC Research and Development approval letters, respectively).
19
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Requirements for acceptance into the SIPU included having been exposed to combat
during the veteran’s military service and having a diagnosis of posttraumatic stress
disorder. Veterans must also have been literate in English, between the ages o f 18 and
75 years, and judged as competent by VA standards. Veterans were considered
inappropriate for the program if they were unable to intellectually comprehend the
information discussed in the program, physically unable to participate in activities
required for the program, actively suicidal, actively psychotic, actively using alcohol
or drugs, or considered unable to benefit from the SIPU by screening staff. All
veterans accepted into the program were offered the opportunity to participate in the
study. Veterans participating in the study completed a 28-day inpatient program for
the treatment of PTSD.
Sixty-two veterans agreed to participate in the study. Seventeen veterans
dropped out of the study before the posttreatment assessment. Of those 45 veterans
who completed both pretreatment and posttreatment assessment, 24 were in the three
cohorts assigned to receive the BA group, while 21 were in the four cohorts assigned
to serve as the comparison group.
Nursing staff asked veterans if they were interested in participating in the
study during the admissions process (see Appendix C for the recruitment script used
by ward nurses and Appendix D for the informed consent meeting scripts). Individuals
willing to participate were scheduled to attend the first assessment session after
signing the informed consent forms. Separate consent forms were used for the
veterans assigned to the BA group (see Appendix E) and the comparison group (see
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Appendix F). All 24 o f the veterans in the BA group attended at least six group
sessions. Two veterans who did not consent to the study also participated in the BA
group. These veterans were allowed to participate in the BA group process, but they
did not complete assessments, had no other data collected on them, and were not
considered study subjects. The provision that veterans would be allowed to
participate in the group process, even if they declined to participate in the study, was
required by the BCVAMC Research and Development Committee.
Procedures
Location
Assessment and treatment sessions were conducted at the BCVAMC in a
group therapy room in building 12. Assessments were done in the testing laboratory
in building 39 and in psychology staff offices in buildings 10 and 12 at the BCVAMC.
Therapists and Independent Assessors
Two therapists provided BA group treatment. The therapist for the first two
BA group cohorts was a psychology intern. He had completed all requirements for
graduation from a clinical psychology doctoral program except his internship and
dissertation. The second therapist facilitated treatment for the third BA group cohort
and was a staff psychologist with a doctorate in clinical psychology. Two staff served
as independent assessors (IAs). The primary IA was a psychology technician with a
BA degree in psychology and who had more than 20 years of experience proctoring
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psychological tests. The backup IA was a psychology technician who had completed
all requirements for graduation from a clinical psychology doctoral program except
his dissertation.
Two masters level social workers and three clinical psychologists completed
the Revised Hamilton Rating Scale for Depression, Clinician Rating Form (RHRSD,
Warren, 1996). They were staff therapists in the SIPU program. These clinical staff
completed the RHRSD for veterans for whom they had been assigned as the primary
therapist in the SIPU.
General Measures
Participants were asked to complete a demographic questionnaire (Appendix
G) developed for use with this study. The demographic questionnaire asked general
questions related to the veteran’s personal background, military service, and
treatment history.
The Millon Clinical Multiaxial Inventory-Third Edition (MCMI-IH; Millon,
Davis, Millon, 1997) is a 175-item self-report inventory that takes 20 to 30 minutes to
complete. The inventory assesses for psychopathology and personality disorders
consistent with DSM-IV diagnostic criteria. Participants respond to statements with
either true or false. It was used in the present investigation to evaluate comorbidity
and Axis H disorders that might complicate the primary disorders under study.
The MCMI-in results include 11 subscales grouped under Clinical Personality
Patterns, 3 subscales under Severe Personality Pathology, 7 subscales under Clinical

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Syndromes, 3 subscales under Severe Clinical Syndromes, and 4 subscales under
Modifying Indices. Generally, base rate scores of 75 or above on a subscaie suggest
that the personality trait associated with that subscale is clinically significant for the
person. Base rate scores of 85 or above on a subscale are indicative of the presence of
pathology associated with that subscale severe enough to be considered a personality
disorder.
Reliability for the MCMI-m was good. Internal consistency among the
subscales was high with Cronbach’s alphas ranging from .66 to .9S. The majority of
alphas were in the .80 to .90 range. Five- to 14-day test-retest reliabilities for the
subscales were strong, with correlations ranging from .82 to .96. Validity measures
for the inventory were also good. Assessments of the presence o f diagnoses by the
inventory were compared with assessments made by clinicians. The proportions of
patients identified with primary diagnoses consistent with clinician ratings ranged
from .30 for the masochistic subscale to .81 for the dependent subscale. Most of the
proportions were above .60. The various subscales were also found to be significantly
correlated with collateral subscales on similar personality inventories, such as the
second edition of the Minnesota Multiphasic Personality Inventory (MMPI-2,
Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) and Symptom Checklist90-Revised (SCL-90-R, Derogatis, 1994).
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Outcome Measures for Depression
The Beck Depression Inventory-Second Edition (BDI-II; Beck, Steer, &
Brown, 1996) is a 21-item self-report inventory that takes 5 to 10 minutes to
complete. The inventory assesses for symptoms of depression. Participants rate their
level of agreement with each question on a scale from 0 to 3. The cutoff scores are 0
to 13 for minimal, 14 to 19 for mild, 20 to 28 for moderate, and 29 to 63 for severe
levels o f depression. It was used in the present investigation as the primary self-report
measures of depression symptoms.
Reliability for the BDI-II was good. Internal consistency was high with a
coefficient alpha of .92 for outpatients and .93 for college students. One-week testretest reliability was strong with a correlation of .93 for outpatients. Validity
measures for the scale were also strong. Convergent validity with the Hamilton
Psychiatric Rating Scale for Depression (Hamilton, 1960) was adequate with a
correlation coefficient of .71. Divergent validity with the Hamilton Rating Scale for
Anxiety (Hamilton, 19S9) was also demonstrated with a correlation of .47. A factor
analysis of the items in the inventory indicated that the scale consisted o f two highly
correlated factors (r = .66), a somatic-affective dimension and a cognitive dimension.
The Beck Hopelessness Scale (BHS; Beck & Steer, 1988) is a 20-item selfreport scale that takes S to 10 minutes to complete. The scale assesses for negative
attitudes about the future. Participants respond to statements with either true or false.
The cutoff scores are 0 to 3 for the minimal range, 4 to 8 for the mild range, 9 to 14
for the moderate range, and greater than 14 for the severe range of hopelessness. It
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was used in the present investigation as a secondary measure of depression and a
measure of the veterans' changes in view in regards to the future.
Reliability measures for the BHS are good. Internal consistency was high with
Kuder-Richardson (KR-20) coefficients ranging from .82 to .93 across seven different
clinical samples. One-week test-retest reliability was adequate with correlations o f .66
and .69 for two separate samples o f subjects. Validity measures for the scale were
also strong. Concurrent validity with clinical ratings was adequate with correlations of
.74 and .62 for subjects taken from a general practice sample and an attempted suicide
sample, respectively. The BDI (Beck & Steer, 1987) and BHS were found to have
correlation coefficients between .46 and .76 across seven different populations.
The Revised Hamilton Rating Scale for Depression-Clinician Rating Form
(RHRSD; Warren, 1996) is a 22-item scale that is completed by the clinician working
with the client and takes 10 to IS minutes to finish. The first question is composed of
8 statements to which the clinician answers yes or no. The remaining 21 questions
consist of a list of statements from which the clinician chooses the statement most
consistent with the client’s current state of functioning. The first question provides a
general screening of the presence or absence of depression. The remaining questions
identify more qualitatively the client’s state of functioning in relation to several
symptoms associated with a diagnosis of major depression. The cutoff for the total
scores are 0 to 10 for not depressed, 11 to 16 for minor depression, 17 to 25 for
major depression, and 26 or greater for severe depression. The scale also indicates the
presence and severity o f major depressive episodes, identifies the presence of
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melancholic features, and provides an estimate of the likelihood that the client’s
symptoms will respond to tricyclic antidepressants. It was used in the present
investigation as the primary clinician rating of major depressive symptoms.
Reliability for the RHRSD is excellent. The internal consistency of the
Clinician Rating Form is good, with a Cronbach’s alpha o f .79. Hedlund and Vieweg
(1979) report convergent validity with other measures o f depression. These authors
found convergent validity with the Beck Depression Inventory (Beck & Steer, 1987)
was good with an average correlation of .67 across 23 studies. The authors also
found that convergent validity with the depression subscale on the Minnesota
Multiphasic Personality Inventory (MMPI, Hathaway & McKinley, 1943) was
adequate with an average correlation of .48 across four studies.
Outcome Measures for PTSD
The Posttraumatic Stress Diagnostic Scale (PDS; Foa, 199S) is a 49-item selfreport measure of the presence and severity of PTSD according to DSM-IV (APA,
1994) diagnostic criteria. The scale takes about 10 tolS minutes to complete. The
PDS provides a rating of the severity of each of the symptoms. The sum of these
ratings indicates the overall severity of PTSD. It was used in the present investigation
to determine the presence of a diagnosis of PTSD and to assess the severity of the
PTSD symptoms.
The PDS has good test-retest reliability with a kappa of .74, 87.3%
agreement in diagnosis over two administrations, and a Pearson correlation coefficient
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of .83 for the Symptom Severity Score. The test’s Symptom Severity Score has
demonstrated good internal consistency with a Cronbach alpha of .92. The PDS has
also demonstrated adequate validity with 79.4% diagnostic agreement with the
Structured Clinical Interview for DSM-IV (SCID; First, Spitzer, Gibbon, & Williams,
1997) (kappa of .59), a sensitivity o f 82% in identifying individuals with PTSD, and a
specificity of 76.7% in identifying individuals without PTSD.
The Mississippi Scale for Combat-Related PTSD (Mississippi; Keane,
Caddell, & Taylor, 1988) is a 35-item self-report inventory that takes 15 to 20
minutes to complete. Questions are answered on a 5-point Likert-type scale. The
scale was designed to measure the intensity of symptoms related to PTSD that have
resulted from experiencing combat. Total scores range from 35 to 175. A cutoff of
107 is usually used to identify individuals who will likely meet diagnostic criteria for
PTSD. It was used in the present investigation as a corroborative measure of PTSD.
This scale is also a more specific measure of the number and severity of symptoms
associated with combat exposure.
The Mississippi scale has demonstrated excellent internal consistency with a
Cronbach alpha of .94 and good 1-week test-retest reliability with a Pearson
product-moment correlation o f .97. The Mississippi scale has also demonstrated good
validity with a sensitivity of 93% in identifying individuals with PTSD, and a
specificity of 89% in identifying individuals without PTSD.
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Additional Questionnaires
The Comprehensive Quality o f Life Scale-Adult Fifth Edition (ComQol;
Cummins, 1997) is a 35-item self-report inventory that takes 15 to 20 minutes to
complete. The inventory assesses seven domains related to a person’s quality of life.
The seven domains are material well-being, health, productivity, intimacy, safety,
place in community, and emotional well-being. Each of the domains is evaluated in
terms of subjective and objective information. This allows for both a measure of the
person’s perception of his or her quality of life and a culturally-relevant assessment of
the person’s quality of life. The ComQol has adequate internal consistency with
Cronbach’s alphas of .54 for the objective subscale and .64 for the subjective subscale
across the seven domains. The author reported that the test has exhibited good
content and construct validity across several studies with various subject populations.
This scale was used in the present investigation to assess for changes in objective and
subjective measures of the quality of the veterans’ lives 1 month after completing
treatment. The scale was also used to examine the veterans’ ratings o f their quality of
life in comparison with a normative sample.
The Concerns About Change Scale (CAC; Vitousek, DeViva, Slay, & Manke,
1995) is a 115-item self-report inventory that takes 10 to 20 minutes to complete. The
scale assesses 17 areas related to a participant’s concern about modifying
dysfunctional behavior. The scale has been modified for this project to include a
subscale addressing the financial effects that may be realized with the removal of
problematic behaviors for which some of the participants will be receiving, or
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attempting to receive, disability payments. This scale was used in the present
investigation to assess for possible factors that may interfere with veterans realizing
meaningful therapeutic change.
The Client Satisfaction Questionnaire (CSQ; Larsen, Attkisson, Hargreaves,
& Nguyen, 1979) is an 8-item self-report inventory that takes 3 to 8 minutes to
complete. Questions are answered on a 4-point Likert-type scale. The scale was
designed to assess client satisfaction with services received in health and human
service systems. The questionnaire’s internal consistency is very good, with
coefficient alphas of .90 to .94 for clients given the measure at two different times
during therapy. The scale was also found to have good construct validity. Low scores
from the scale were significantly correlated to dropout and missed appointment rates.
Scores from the scale also correlated with client self-rating of improvement from
therapy and therapist estimates of client satisfaction. This scale was used in the
present investigation to examine the veterans’ response to the BA group process in
terms of satisfaction with the intervention and perceived utility of the group.
Tests Completed at the Assessment Times
Pretreatment Assessment
During the first assessment session, the veterans were asked to complete the
MCMI-in, BDI-II, BHS, PDS, Mississippi, ComQol, and CAC. The veterans were
also asked to complete the demographic questionnaire.
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Posttreatment Assessment
During this session, the veterans were asked to complete the BDI-II, BHS,
PDS, Mississippi, and CAC. After completing these measures, the veterans were
scheduled for a 1-month follow-up assessment.
1-month Follow-up Assessment
During this session, the veterans were asked to complete the BDI-II, BHS,
PDS, Mississippi, and ComQol. After completing these measures, the veterans were
scheduled for a 2-month follow-up assessment.
2-Month Follow-up Assessment
During this session, the veterans were asked to complete the BDI-II, BHS,
PDS, and Mississippi After finishing these measures, the veterans had completed the
study.
Additional Assessments
The RHRSD was completed by the primary therapists shortly after the
veterans were admitted into the SIPU and within 1 week before the veterans were
discharged from the SIPU. The veterans were scheduled for appointments with their
primary therapists on the same days they had been scheduled for their 1-month and 2month follow-up assessments. The primary therapists completed the RHRSD during
each these appointments.
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The BA group therapist administered the BDI-II to all participants at the start
o f every-other BA group session, beginning with session 2. This was done to assess
the participants’ depressive symptoms during treatment. The group therapist also
administered the CSQ at the end of the final group session.
Data Management
After testing was complete, data from the study were stored in locked cabinets
in buildings 39 and 12. The master list of names of subjects and consent forms were
stored in locked cabinets in building 13. After completion o f scoring and data entry a
file for each subject was created and the files were stored in building 12 in a locked
cabinet. Research files were maintained in a secure manner by the psychology service
at the BCVAMC.
Treatment Description
Standard Treatment
The SIPU is a ward on the grounds of the BCVAMC that houses a specialized
treatment program developed for addressing PTSD. The treatment program was
described above (see Appendix H for the weekly program schedule for the
comparison group).
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Standard Treatment Plus Behavioral Activation
In addition to the standard treatment, group cohorts who were selected to
receive the behavioral activation treatment attended eight group sessions. The
sessions occurred twice a week and each session lasted 60 to 90 minutes. The
treatment was an adaptation of the behavioral activation treatment developed by
Jacobson and his colleagues (Jacobson, 1997). The behavioral activation procedure
used for this study was modified from individual to group format and adapted to fit
into a residential treatment program (see Appendix I for the weekly program schedule
for the BA group).
A manual was used by the therapist for facilitating the group. Each group
member received a handout packet that included an outline o f each session,
descriptions of topics covered, and homework assignments. The general format for
each o f the group sessions included an opening, review of homework, discussion of
two to three psychoeducational topics, assessment of groups members’ understanding
o f the topics, identification of examples from group members related to topics
discussed, homework assignment, and closing (see Appendix J for an outline of the
BA group format).
The first and last sessions were slightly different. In the first session, group
members and the therapist introduced themselves, ground rules were established in
the group, the modified group therapy version (Porter, 2000) o f the Jacobson (1997)
Coping with Depression: A Manualfo r Self-Help was reviewed, the idea of therapist
as a personal trainer was discussed, the functional analysis topic was covered, and
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homework was assigned. In the last session, homework was reviewed, a brief
overview of all of the topics from previous groups was completed, individual
members’ progress was discussed, skills learned to be used for relapse prevention
were highlighted, the therapist provided feedback regarding the group process,
goodbyes were completed, and the CSQ was administered.
All other sessions followed the general format. Psychoeducation was used to
inform participants about theoretical explanations of the possible etiology of
depression, to develop coping skills, and to increase behavior. Psychoeducational
topics discussed included assertiveness, self-defeating behaviors, aversive
environments, activity mastery and pleasure, activity monitoring, active versus passive
approaches to problems, graded task assignment, behavioral stopping, alternative
behaviors and outcomes, self-reinforcement, distraction from problems or unpleasant
events, role-playing social situations, and mental rehearsal of activities. Several
different resources were used to develop explanations of these topics (Adesso, 1990;
Beck, Rush, Shaw, & Emery, 1979; Emery, 1988; Jacobson, 1997; Leahy & Holland,
2000; Yost, Beutler, Corbishley, & Allender, 1986). Examples that were applicable to
the veterans were provided for each of the topics. Although therapists were given the
freedom to present topics in any order, the order listed above was suggested and was
used with each o f the three BA group cohorts (see Appendix K for an outline of the
BA group sessions).
Homework assignments involved individuals identifying activities considered
pleasurable and increasing incrementally the number of activities completed between

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

34
each session. Homework assignments also involved applying newly learned skills
covered in the session to personal problems (see Appendix L for the therapist rating
of homework completion form). The BDI-U was administered at the start of sessions
2,4, 6, and 8.
Treatment Integrity
Four approaches to maintaining treatment integrity were used. First, the two
therapists received training for facilitating the behavioral activation group treatment.
Second, one retraining session was provided after 3 months. Third, a treatment
manual was given to therapists outlining the course of treatment. Therapists were
strongly encouraged to review the treatment manual on an ongoing basis and use it
during the session. Finally, self-rating sheets were completed by the therapists
immediately after each session (see Appendix M for therapist self-rating sheets for
each session). During the course of the study, the therapists spontaneously began
using these self-rating sheets as reminders before and during the sessions. The rating
scale was structured from 0 (did not do the assigned task) to 4 (did every last bit of
the task). Twelve to 16 tasks were rated for each of the sessions. The overall average
self-ratings were 3.44 for the first group, 3.42 for the second group, and 3.63 for the
third group. Compliance with the treatment regimen was, therefore, between 85% and
91% according to therapist self-ratings.
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CHAPTER m
RESULTS
Hypotheses
It was hypothesized that subjects receiving the behavioral activation treatment
would show a decrease in symptoms of depression, would experience a decrease in
PTSD symptoms, and that several factors would predict treatment effectiveness.
Among the factors thought to predict treatment effectiveness were included “service
connection,” “therapist ratings of homework completion,” and “syndrome severity.”
Plan for Data Analyses
The study utilized a 2 x 4 mixed design. The between groups factor was group
assignment (BA group and comparison group). The within groups factor was the time
of assessment (pretreatment, posttreatment, 1-month follow-up, and 2-month followup). To test the first and second hypotheses a two-factor repeated measures analysis
of variance were completed with the BDI-H, BHS, RHRSD, PDS, and Mississippi
Scale as dependent measures. Follow-up analyses for significant F tests included one
way repeated measures ANOVAs. Paired t tests with Bonferroni adjustments of alpha
levels (Pallant, 2001) to control for inflated type 1 error were used to test simple main
effects when main effects were significant.

35
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Cany forward analyses were completed to address missing data due to
veterans dropping out o f the study over assessment times. This analysis consisted of
carrying forward the last data point for each of the subjects who did not complete 1month or 2-month follow-up testing to the subsequent assessment times. Veterans
who did not complete both pretreatment and posttreatment assessments were not
included in this analysis. A two-factor repeated measures ANOVA was completed
with the BDI-n, BHS, RHRSD, PDS, and Mississippi after the carry forward
procedure was applied. Follow-up analyses for significant F tests included one-way
repeated measures ANOVAs to assess for significant main effects and interactions.
Paired t tests with Bonferroni adjustments of alpha levels were used to test for
significant simple main effects.
The third hypothesis was examined through multiple regression analyses. A
difference score was computed between pretreatment and 2-month follow-up for both
the PDS symptom severity score and the Mississippi total score to represent two
measures of changes in PTSD symptoms over the course o f the study. A difference
score was computed between pretreatment and 2-month follow-up for both the BDIII total score and RHRSD total score to represent two measures o f change in
depressive symptoms over the course o f the study. Variables that were significantly
correlated using the Pearson product-moment correlation with change scores on the
various psychological tests among the four assessment times were used as predictor
variables. Predictor variables included in the multiple regression from the CAC
consisted of scores on a subscale associated with the “belief that one is unable to
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change” and a subscale associated with “fear o f the process required for change.”
Predictor variables from the MCMI-in included base-rate scores for “desirability” and
a difference score calculated by subtracting base rates of the desirability scale from
base rates o f the debasement scales. Predictor variables from the demographic
questionnaire included a difference score calculated by subtracting percentage of
current PTSD service connection from desired PTSD percentage o f service
connection and a “current total service connection” score. The final predictor variable
was “therapist ratings of homework completion” for veterans in the BA group.
Clinical significance was examined using RHRSD total scores collapsed into
four categories (not depressed, minor depression, major depression, severe
depression) and then two categories (no to mild depression and major to severe
depression). The Friedman test was used to explore for significant changes in levels of
depression over the four assessment times for the BA and comparison group
separately. Significant differences identified by the Friedman tests were followed up
with Wilcoxon Signed Rank Tests to determine where the significant differences
existed. Chi-square tests were used to assess for significant differences in changes in
depression diagnosis between the BA group and comparison group for each o f the
four assessment times.
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Preliminary Analyses
Drop Out Analyses
Sixty-two veterans agreed to participate in the study. Thirty veterans were
assigned to the BA group and 32 veterans were assigned to the comparison group.
Seventeen o f these veterans did not complete both pretreatment and posttreatment
assessments. O f these 17, 1 veteran assigned to the BA group and 2 veterans assigned
to the comparison group did not finish the pretreatment assessment. The remaining 14
veterans completed pretreatment assessment, but did not complete posttreatment
assessment (S had been assigned to the BA group and 9 had been assigned to the
comparison group). Fifteen of the remaining 45 veterans did not complete the lmonth follow-up assessment (10 veterans from the comparison group and 5 veterans
from the BA group) and 10 more did not complete the 2-month follow-up (4 veterans
from the comparison group and 6 veterans from the BA group). Veterans completing
assessments in the comparison group included 21 at pretreatment and posttreatment,
11 at the 1-month follow-up, and 7 at the 2-month follow-up. Those veterans in the
BA group who completed the assessments included 24 at pretreatment and
posttreatment, 19 at the 1-month follow-up, and 13 at the 2-month follow-up (see
Figure 1).
A Friedman test was conducted to evaluate the differences in mean ranks of
veteran’s dropping out of the study from the BA group at pretreatment (mean rank =
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Figure 1. Number o f Veterans at Each Assessment Time for the Two Groups.
3.02), posttreatment (mean rank = 2.68), 1-month follow-up (mean rank = 2.35), and
2-month follow-up (mean rank = 1.95) and for the comparison group at pretreatment
(mean rank = 3.30), posttreatment (mean rank = 2.73), 1-month follow-up (mean
rank = 2.11), and 2-month follow-up (mean rank = 1.86). The test was significant for
2

the treatment group x (3, N = 30) = 31.87, p < .0005 and for the comparison group
2

x (3, N= 32) = 48.72, p < .0005. Follow-up comparisons were conducted using
Wilcoxon Signed Ranks tests. There was a significant drop out of subjects from
pretreatment to posttreatment ip = .025), posttreatment to 1-month follow-up ip =
.025), and 1-month follow-up to 2-month follow-up (p = .014) for the BA group.
There was a significant drop out of subjects from pretreatment to posttreatment ip —
.003), posttreatment to 1-month follow-up (p = .002), and 1-month follow-up to 2month follow-up (p —.046) for the comparison group.
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A chi-square test was conducted to assess whether the difference between the
BA group and comparison group in the number o f subjects that dropped out at each
assessment time was statistically significant. The results o f these tests were not
2

significant for pretreatment x (1,

2

62) = 0, p = 1.0, posttreatment x (1, N= 62) =

.967, p = .33, or 2-month follow-up x \ i , N= 62) = 2.36, p = .13. The test was
2

significant for the 1-month follow-up assessment x (1, Ar= 62) = 4.10, p = .04 with
significantly more subjects dropping out o f the comparison group (10) than BA group
( 5).
Demographics
The participants in this study were all male combat veterans. The veterans
were primarily Caucasian with 2 to 3 years of military service (see Table 1 for
demographic data). The majority of veterans were receiving medications for
depression and anxiety symptoms. All o f the veterans were diagnosed with PTSD and
the majority of the veterans were rated to have at least minor depression by therapists
using the RHRSD.
Service connection is a term used in the VA system to describe the degree o f
service-related disability encountered by veterans. Funds are provided by the
Department of Veteran Affairs for injuries or illnesses acquired by veterans while they
are in the service. These funds are called “service connection” and can range from 0%
to 100%. Service connection funds can be collected for both physical and psychiatric
conditions. In theory, the higher the percentage of service connection, the more
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Table 1
Frequency and Percentage o f Demographic Characteristics Between Groups
Comparison Group

BA Group

Age
4 0 -4 5
4 6 -5 0
5 1 -5 5
5 6 -6 0

0 ( 0%)
6 (28.6%)
12(57.1%)
3 (14.3%)

2 ( 8.3%)
3 (12.5%)
16 (66.7%)
3 (12.5%)

African American
Native American
Hispanic
Caucasian

6 (28.6%)
1 ( 4.8%)
0 ( 0%)
14 (66.7%)

9 (37.5%)
2 ( 8.3%)
2 ( 8.3%)
11 (45.8%)

Single
Married
Separated
Divorced

4 (19%)
6 (28.6%)
5 (23.8%)
6 (28.6%)

0 ( 0%)
10 (41.7%)
2 ( 8.3%)
12 (50%)

Less than 12 Years
12 years
13 to 16 years
More than 16 years

9 (42.9%)
5 (23.8%)
7 (33.3%)
0 ( 0%)

5 (20.8%)
7 (29.2%)
11 (45.8%)
1 ( 4.2%)

12(57.1%)
5 (23.8%)
4(19.1%)

16 (66.7%)
5 (20.8%)
3 (12.5%)

Months in Combat
Less than 12 months 10 (47.6%)
12 months
6 (28.6%)
More than 12 months 5 (23.8%)

6 (25%)
10 (41.7%)
8(33.3%)

Injured in Combat
No
Yes

12 (50%)
12 (50%)

Race

Marital Status

Education

Years Military Service
2 to 3 years
4 to 5 years
6 to 7 years

8(38.1%)
13 (61.9%)

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

42
Table 1—Continued
Comparison Group

BA Group

Received Inpatient Treatment for Depression
No
11 (52.4%)
Yes
10 (47.6%)

8 (33.3%)
16 (66.7%)

Prescribed Antidepressants
No
Yes

1 ( 4.8%)
20 (95.2%)

1 ( 4.2%)
23 (95.8%)

Prescribed Anxiolytics
No
Yes

5 (23.8%)
16 (76.2%)

7 (29.2%)
17 (70.8%)

Therapist Ratings of Depression Pretreatment with RHRSD
Not Depressed
1 ( 4.8%)
Minor Depression
11(52.4%)
Major Depression
6 (28.6%)
Severe Depression
2 ( 9.5%)

4 (16.7%)
7 (29.2%)
12 (50%)
1 ( 4.2%)

debilitating the condition. Table 2 lists percentage o f PTSD “current service
connection” and percentage of “wanted service connection” by veterans in the study.
Veterans in the study were administered the MCMI-III to assess for level of
psychological pathology. Millon et al. (1997) report that base rates above 75 on
clinical scales is indicative o f the presence o f clinically significant personality traits,
while scores above 85 are indicative of the prominence o f significant personality
traits. Twelve out o f 24 base rates scores for the various clinical scales were greater
than 75 for the comparison group, while 13 of the clinical scales were above 75 for
the BA group (see Table 3 for MCMI-III base rates).
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Table 2
Frequency and Percentage o f Service Connection Between Groups
Comparison Group

BA Group

Current PTSD Service Connection
0%
10-30%
40-60%
70%

16 (76.2%)
2 ( 9.5%)
2 ( 9.5%)
I ( 4.8%)

14 (58.3%)
3 (12.5%)
7 (29.2%)
0 ( 0%)

PTSD Service Connection Wanted
0%
10-30%
50-70%
100%

6 (28.6%)
0 ( 0%)
2 ( 9.5%)
13 (61.9%)

5 (20.8%)
1 ( 4.2%)
2 ( 8.3%)
16 (66.7%)

Five o f the base rate scores for clinical scales were above 8S for the
comparison group, while three of the clinical scales were above 85 for the BA group.
Base rate scores above 75 on the debasement scale are suggestive o f the tendency to
devalue oneself Independent t tests were completed to assess for significant
differences in mean base rates between the two groups for all o f the scales. No
significant differences in mean base rate scores between groups were found for any of
the scales.
The Comprehensive Quality o f Life Scale - Adult Fifth Edition (ComQol)
(Cummins, 1997) was administered to veterans at the pretreatment and 1-month
follow-up assessment times. Table 4 displays the results from these two assessment
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Table 3
Mean Base Rate MCMI-III Scores Between Groups
Scale

Comparison Group

BA Group

Modifying Indices
Disclosure
Desirability
Debasement

84.62
29.86
86.24

89.71
34.83
87.96

Clinical Personality Patterns
Schizoid
Avoidant
Depressive
Dependent
Histrionic
Narcissistic
Antisocial
Sadistic
Compulsive
Passive-Aggressive
Masochistic

86.57
85.38
83.52
69.76
13.67
27.48
71.24
65.52
24.67
77.76
75.71

81.75
82.29
78.42
69.71
14.33
34.79
68.75
65.79
26.50
83.54
78.12

Severe Personality Pathologv
Schizotypal
Borderline
Paranoid

80.14
74.19
67.38

74.83
75.79
80.08

Clinical Syndromes
Anxiety
Somatoform
Bipolar: Manic
Dysthymia
Alcohol Dependence
Drug Dependence
PTSD

98.71
76.76
57.57
91.38
78.10
71.81
92.81

97.33
77.29
63.54
93.67
78.37
71.92
87.33

Severe Clinical Svndromes
Thought Disorder
Major Depression
Delusional Disorder

74.43
83.38
52.95

71.62
84.50
60.92
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Table 4
ComQol Means for the Two Groups at Two Assessment Times
and for a Norm Group
Comparison Group

BA Group

Pre

1-Month

Pre

6.81
6.38
6.71
8.00
6.62
6.00
6.86
47.38

6.82
5.91
7.00
7.27
7.00
5.00
6.27
45.27

7.54
5.83
6.54
7.25
6.96
5.96
7.46
47.54

7.42
5.42
6.74
7.21
6.53
5.95
7.11
46.37

10.07
12.88
10.64
11.38
12.36
7.55
10.71
75.59

Subjective Imnortance x Satisfaction Scales
3.58
-1.64
2.90
Material
-1.00
-2.57
-3.36
Health
-1.62
-2.10
Productivity
-1.82
-2.67
.76
.18
Intimacy
-1.04
-2.76
-3.36
Safety
-.83
-.86
-.64
Community
-3.58
-2.90
-2.55
Emotional
-7.16
-7.53
-13.19
Total Subjective

4.05
-1.84
-2.47
-2.42
-2.00
-.68
-3.00
-8.36

8.23
8.77
7.61
11.75
9.86
6.99
8.87
62.08

Subscales
Objective Scales
Material
Health
Productivity
Intimacy
Safety
Community
Emotional
Total Objective

1-Month

Norm Group

Note. Pre = Pretreatment, 1-Month = 1-Month Follow-up, Norm Group = Random
Group o f794 Adults Tested by Cummins (1997).
times compared with a normative sample consisting of a random sample o f794 adults
with a mean age of 51 years (Cummins, 1997).
Paired t tests were conducted on each o f the scales for both groups. No
significant differences were found from pretreatment to 1-month follow-up for the
comparison or BA groups on any of the scales except for the “total objective” score
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for the comparison group, p = .014. The overall objective score for the veterans in the
comparison group decreased significantly from pretreatment to 1-month follow-up.
Independent samples t tests were conducted to examine for significant differences
between groups at each assessment time. There were no significant differences
between the comparison and BA group at pretreatment. A significant difference was
found between the comparison and BA group at the 1-month follow-up for the
subjective material well-being subscale, p = .02. Veterans in the BA group indicated
that they believed they were better off financially at the 1-month follow-up than the
comparison group. No other significant differences were found between the two
groups on the subjective scales at the 1-month follow-up.
Primary Analyses
Treatment Outcome With the BDI-II
Figure 2 presents the mean scores for the BDI-II for the BA and comparison
groups across the four assessment times and the dropout groups at pretreatment. A
one-way analysis of variance (ANOVA) was conducted to determine if there was a
significant difference between the mean BDI-n scores for the comparison group (M =
37.38), BA group (M= 38.29), veterans assigned to the comparison group who
dropped out before posttreatment assessment (A/ = 34.56), and veterans assigned to
the BA group who dropped out before posttreatment assessment (M = 41.80). The
ANOVA was not significant, F(3, 55) = .72, p = .55, indicating that the BDI-II means
for the groups did not differ significantly at pretreatment.
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Figure 2. BDI-II Total Score Means for the Different Groups Over the Four
Assesment Times.
A two-factor repeated measures analysis o f variance was completed to
examine the differences between groups in change in BDI-II scores over the four
assessment times. The time main effect was not significant, F(3, 54) = 1.36, p = .27,
2

n = .07. The time x group interaction effect was not significant, F (3, 54) = 1.03, p =
2

.39 n = .05. The univariate test associated with the between-groups main effect was
also not significant, F (l, 18) = .76, p = .40 n2 = .04. The eta squared statistic (n2)
indicated a moderate effect size for the time main effect and a small effect size for the
interaction and between groups main effect (Cohen, 1988).
Despite the lack o f statistical significance using this test and due to the loss of
power from subject drop out, the graphs of means scores were visually inspected and
paired t tests were completed to assess for significant within groups changes over
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time. Bonferroni adjustments were made for the alpha levels. For the comparison
group, a significant difference was found from 1-month follow-up (AS= 38.S7, SD =
8.62) to 2-month follow-up (AS= 42.57, SD = 9.78), 1(6) = -4.58, p = .004. Veterans
in the comparison condition scored significantly higher on the BDI-II at the 2-month
follow-up than at the 1-month follow-up. For the BA group, a significant difference
found was from pretreatment (AS= 38.29, SD = 9.25) to posttreatment (AS= 31.54,
SD = 15.19), /(23) = 3.31 ,p = .003. Veterans in the treatment condition scored
significantly lower on the BDI-II at posttreatment than at pretreatment.
Four independent sample t tests were completed to assess for significant
differences between the BA group and comparison group for each of the four
assessment times. No significant differences were found (see Table 5 for BDI-H
means, standard deviations, and t test results).
Carry forward analyses were also completed with the BDI-II to address loss
of power due to drop out. Figure 3 presents the mean scores for the BDI-II for the
BA and comparison groups over the four assessment times after the last data point
was carried forward.
A two-factor repeated measures analysis o f variance was conducted to
examine the differences between groups in change in BDI-II scores over the four
assessment times after carry forward adjustments were completed. Due to the lack of
sphericity, the time main effect and time x group interaction effect were tested using
the multivariate criterion of Wilks’ lambda. The time main effect was not significant,
Wilks’ lambda = .87, F(3, 41) = 1.97, p = .13, n" = .13. The time x group interaction
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TableS
BDI-II Score Means, Standard Deviations, and Independent Samples t Tests
Across the Four Assessment Times
BA Group
N
Pretreatment
Posttreatment
1-month
2-month

24
24
19
13

M

SD

38.29 9.25
31.54 15.19
36.68 15.36
34.15 16.24

Comparison Group
N

M

SD

t(df)m&p

21
21
11
7

37.38
37.81
39.00
42.57

7.75
8.26
7.22
9.78

/(43) = -.36, p = .72
t(43) = 1.68, p = .10
f(28) = .47, p = .64
r(18) = 1.25, p = .23

Note. N = Number of Veterans, M = Mean Scores, SD = Standard Deviation, df=
Degrees of Freedom.
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Figure 3. Carry Forward BDI-II Total Score Means for the Two Groups Over the
Four Assessment Times.

effect was significant, Wilks’ lambda = .80, F(3,41) = 3.37, p = .03, n2 = .20. The
univariate test associated with the between groups main effect was not significant,
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2

F (l, 43) = 1.09, p = .30, n - .02. The eta squared statistic indicated a moderate
effect size for the time main effect, a large effect size for the interaction, and a small
effect size for the between groups main effect.
Three paired *tests were completed to follow up the significant interaction.
Differences in mean BDI-II scores between the two groups were significantly
different between pretreatment and posttreatment, *(43) = -2.48, p = .017, but not
between posttreatment and 1-month follow-up, *(43) = 1.55, p = .13 or 1-month
follow-up and 2-month follow-up, *(43) = -1.54,

= . 13.

Treatment Outcome With the BHS
Figure 4 presents the mean scores for the Beck Hopelessness Scale (BHS) for
the BA and comparison groups across the four assessment times and dropout groups
at pretreatment. A one-way analysis of variance (ANOVA) was conducted to
determine if there was a significant difference between the mean BHS scores for the
comparison group (M= 13.76), BA group (M — 12.25), veterans assigned to the
comparison group who dropped out before posttreatment assessment (M = 11.86),
and veterans assigned to the BA group who dropped out before posttreatment
assessment (M = 14.60). The ANOVA was not significant, F(3, 53) = .48, p - 69,
indicating that the BHS means for the groups did not differ significantly at
pretreatment.
A two-factor repeated measures analysis of variance was completed to
examine the differences between groups in change in BHS scores over the four
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Figure 4. BHS Total Score Means for the Different Groups Over the Four
Assessment Times.
assessment times. Due to the lack of sphericity, the time main effect and time x group
interaction effect were tested using the multivariate criterion of Wilks’ lambda. The
time main effect was not significant, Wilks’ lambda = .76, F(3, 16) = 1.68, p = .2 1 ,
2

n = .24. The time x group interaction effect was not significant, Wilks’ lambda = .74,
2

F(3,16) = 1.91, p = .17, n = .26. The univariate test associated with the between
2

groups main effect was not significant, F (l, 18) = 2.14,/; = .16, n = 11. The eta
squared statistic indicated a large effect size for the time main effect and the
interaction and a moderate effect size for the between groups main effect.
Despite the lack o f statistical significance using this test and due to the loss of
power from subject drop out, the graphs of means scores were visually inspected and
paired t tests were completed to assess for significant within groups changes over
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time. Paired t tests were completed to assess for significant within groups mean
changes. No significant differences were found for either the comparison or BA
groups.
Four independent sample t tests were completed to assess for significant
differences between the BA group and comparison group for each o f the four
assessment times. A significant difference was found between the comparison group
and the BA group, /(18) = 2.30, p = .03 at the 2-month follow-up. Mean BHS scores
were significantly higher for the comparison group than the BA group at the 2-month
follow-up (see Table 6 for BHS means, standard deviations, and t test results).
Table 6
BHS Score Means, Standard Deviations, and Independent Samples
t Tests Across the Four Assessment Times
BA Group

Pretreatment
Posttreatment
1-month
2-month

N

M

SD

24
24
19
13

12.25
13.46
14.79
12.92

5.76
5.34
4.26
6.33

Comparison Group
N
21
21
11
7

M
13.76
13.95
16.00
17.57

SD
5.06
4.20
3.82
2.64

t(dj) and p
/(43)= .93, p =
/(43) = .34, p =
K28)= .77, p =
/(18) = 2.30,/> =

.36
.73
.44
.03

Note. N -Num ber of Veterans, M = Mean Scores, SD = Standard Deviation, df=
Degrees of Freedom.
Carry forward analyses were also completed with the BHS to address loss of
power due to drop out. Figure S presents the mean scores for the BHS for the BA
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and comparison groups over the four assessment times after the last data point has
been carried forward.

CO

09
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1 (H
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Assessment Times
Figure 5. Carry Forward BHS Total Score Means for the Two Groups Over the Four
Assessment Times.
A two-factor repeated measures analysis of variance was conducted to
examine the differences between groups in change in BHS scores over the four
assessment times after carry forward adjustments were completed. Due to the lack of
sphericity, the time main effect and time x group interaction effect were tested using
the multivariate criterion of Wilks’ lambda. The time main effect was not significant,
Wilks’ lambda = .84, F (3 ,41) = 2.67, p = .06, #i2 = .16. The time x group interaction
effect was not significant, Wilks’ lambda = .93, F(3,41) = 1.02, p = .39, n2 = .07.
The univariate test associated with the between groups main effect was not
significant, F (l, 43) = .25, p = .62, n =.01. The eta squared statistic indicated a
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large effect size for the time main effect, a moderate effect size for the interaction,
and a small effect size for the between groups main effect.
Treatment Outcome With the RHRSD
Figure 6 presents the mean scores for the RHRSD for the BA and comparison
groups across the four assessment times and the dropout groups at pretreatment. A
one-way analysis o f variance (ANOVA) was conducted to determine if there was a
significant difference between the mean RHRSD scores for the comparison group
( M - 16.55), BA group (M = 16.62), veterans assigned to the comparison group who
dropped out before posttreatment assessment (AS= 16.17), and veterans assigned to
the BA group who dropped out before posttreatment assessment (AS= 20.25). The
ANOVA was not significant, F(3, 50) = .50, p = .68, indicating that the RHRSD
means for the groups did not differ significantly at pretreatment.
A two-factor repeated measures analysis o f variance was completed to
examine the differences between groups in change in RHRSD scores over the four
assessment times. The time main effect was significant, F(3, 57) = 6.09, p = .001,
2

n = .24. The time x group interaction effect was not significant, F (3, 57) = .56, p
2

= .65, n = .03. The univariate test associated with the between-groups main effect
was also not significant, F (l, 19) = .48, p = .50, n = .02. The eta squared statistic
indicated a large effect size for the time main effect and a small effect size for the
interaction and between groups main effect.
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Figure 6. RHRSD Total Score Means for the Different Groups Over the Four
Assessment Times.
Two one-way repeated-measures analysis o f variance (repeated measures
ANOVA) tests were conducted to examine the significant time main effect for each of
the groups (see Table 7 for RHRSD means and standard deviations).
The results for the comparison group were not significant, F (3 ,21) = 1.22,
p = .33. The results for the treatment group were significant, F(3, 36) = 7.16, p .001. Six paired t tests were completed to follow up the significant repeated measures
ANOVA. Bonferroni adjustments o f alpha levels were used to control for inflated
type I error. Differences in mean RHRSD scores across assessment times for the BA
group were significantly different between pretreatment and posttreatment, /(23) =
4.94, p < .0005, pretreatment and 2-month follow-up, /(12) = 4.66, p = .001,
posttreatment and 1-month follow-up, /(18) = -2.22, p = .04, and 1-month follow-up
and 2-month follow-up, 1(12) = 3.36, p = .006, but not between pretreatment and
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Table 7
RHRSD Total Score Means and Standard Deviations
From the Mixed ANOVA Analysis
BA Group

Pretreatment
Posttreatment
1-month
2-month

Comparison Group

N

M

SD

N

M

SD

13
13
13
13

18.08
13.08
15.54
11.92

6.32
5.11
6.01
4.23

8
8
8
8

15.62
11.87
13.37
12.37

5.73
5.28
4.81
6.00

Note. N = Number o f Veterans, M - Mean Scores, SD = Standard Deviation.
1-month follow-up, /(18) = 1.38, p = . 18 or posttreatment and 2-month follow-up,
/(12) = -1.05, p = .32. BA group veterans’ RHRSD scores decreased significantly
from pretreatment to posttreatment, pretreatment to 2-month follow-up, and 1-month
follow-up to 2-month follow-up. BA group scores increased significantly from
posttreatment to 1-month follow-up.
Carry forward analyses were also completed with the RHRSD to address loss
o f power due to drop out. Figure 7 presents the mean scores for the RHRSD for the
BA and comparison groups over the four assessment times after the last data point
was carried forward.
A two-factor repeated measures analysis of variance was conducted to
examine the differences between groups in change in RHRSD scores over the four
assessment times after carry forward adjustments were completed. Due to the lack of
sphericity, the time main effect and time x group interaction effect were tested using
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Figure 7. Carry Forward RHRSD Total Score Means for the Two Groups Over the
Four Assessment Times.
the multivariate criterion o f Wilks’ lambda. The time main effect was significant,
Wilks’ lambda = .57, F(3, 40) = 9.93, p < .0005, n = .43. The time x group
interaction effect was not significant, Wilks’ lambda = .93, F(3, 40) = .93, p = .44,
2

n = .06. The univariate test associated with the between groups main effect was not
significant, F (l, 42) = .57, p = .45, n = .01. The eta squared statistic indicated a
large effect size for the time main effect, a moderate effect size for the interaction,
and small effect size for the between groups main effect.
Two one-way repeated-measures analysis of variance tests were conducted to
examine the significant time main effect for each o f the groups (see Table 8 for carry
forward RHRSD means and standard deviations).
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Table 8
Cany Forward RHRSD Total Score Means and Standard Deviations
From the Mixed ANOVA Analysis
BA Group

Pretreatment
Posttreatment
1-month
2-month

Comparison Group

N

M

SD

N

M

SD

24
24
24
24

16.62
11.87
13.92
11.96

5.80
4.48
5.17
3.75

20
20
20
20

16.55
13.05
14.40
14.00

5.29
5.22
4.87
5.44

Note. N = Number of Veterans, M = Mean Scores, SD = Standard Deviation.
The results for the comparison group were analyzed with the multivariate
criterion o f Wilks’ lambda due to the lack o f sphericity. The results were not
significant, Wilks’s lambda = .75, F(3, 17) = 1.84, p = . 18. The results for the BA
group met the assumption of sphericity and were significant, F(3, 69) = 11.02, p <
.0005. Sue paired t tests were completed to follow up the significant repeated
measures ANOVA. Bonferroni adjustments o f alpha levels were used to control for
inflated type 1 error. Differences in mean RHRSD scores across assessment times for
the BA group were significantly different between pretreatment and posttreatment,
/(23) = 4.94, p < .0005, pretreatment and 2-month follow-up, f(23) = 4.68,/? < .0005,
and 1-month follow-up and 2-month follow-up, /(23) = 2.86,/? = .009. Differences
between pretreatment and 1-month follow-up, /(23) = 2.25, p = .03, posttreatment
and 1-month follow-up, f(23) = -2.17,/? = .04, and posttreatment and 2-month
follow-up, /(23) = -. 10, p = .92 were not significant after applying the Bonferroni
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adjustments o f alpha levels. BA group veterans’ RHRSD scores decreased
significantly from pretreatment to posttreatment, pretreatment to 2-month follow-up,
and 1-month follow-up to 2-month follow-up.
Treatment Outcome With the PDS
Figure 8 presents the mean scores for the PDS for the BA and comparison
groups across the four assessment times and the dropout groups at pretreatment. A
one-way analysis of variance (ANOVA) was conducted to determine if there was a
significant difference between the mean scores for the comparison group (M = 43.19),
BA group (M = 45.00), veterans assigned to the comparison group who dropped out
before posttreatment assessment (M = 40.22), and veterans assigned to the BA group
who dropped out before posttreatment assessment (M= 38.60). The ANOVA was
significant, F(3, 55) = 3.55, p = .02, indicating that the BHS means for the groups
may differ significantly at pretreatment. However, follow-up tests using the Tukey
HSD test did not find significant differences among the four groups (see Table 9 for
PDS symptoms severity score mean differences, standard errors, and alpha levels
among the four groups), indicating that the PDS means for the groups did not differ
significantly at pretreatment.
A two-factor repeated measures analysis o f variance was completed to
examine the differences between groups in change in PDS scores over the four
assessment times. The time main effect was not significant, F(3, 54) = .27, p = .85,
2

n = .01. The time x group interaction effect was not significant, F(3, 54) = 1.72,

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

60

IComparison Group

IBA Group
&

B Comparison Group
DropOut
IBA Group Drop Out

38

PieTreatment

PojtTreatment

1 Month
Follow-up

2 Month
Follow-up

Assessment Times
Figure 8. PDS Symptom Severity Score Means for the Different Groups Over the
Four Assessment Times.
Table 9
PDS Symptom Severity Score Mean Differences, Standard Errors,
and Alpha Levels Among the Four Groups
Groups

Mean
Difference

Comparison and BA
Comparison and Comparison Dropouts
Comparison and BA Dropouts
BA and Comparison Dropouts
BA and BA Dropouts
Comparison Dropouts and BA Dropouts

-1.81
2.97
4.59
4.78
6.40
1.62

Standard
Error

p

1.48
1.98
2.47
1.94
2.44
2.77

.617
.444
.257
.077
.053
.936

2

p = . 17, n = .09. The univariate test associated with the between groups main effect
2
was also not significant, F (l, 18) = .29, p = .59, n = .02. The eta squared statistic
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indicated a small effect size for the time main effect and between groups main effect
and a moderate effect size for the interaction.
Despite the lack o f statistical significance using this test and due to the loss of
power from subject drop out, the graphs o f means scores were visually inspected and
paired t tests were completed to assess for significant within groups mean changes.
No significant differences were found for either the comparison or BA groups. Four
independent samples t tests were completed to assess for significant differences
between the BA group and comparison group for each of the four assessment times.
No significant differences were found between the comparison and BA groups at any
of the assessment times (see Table 10 for PDS symptom severity score means,
standard deviations, and t test results).
Table 10
PDS Symptom Severity Score Means, Standard Deviations, and Independent Samples
t Tests Across the Four Assessment Times
BA Group

Pretreatment
Posttreatment
1-month
2-month

Comparison Group

N

M

SD

N

M

24
24
19
13

45.00
43.67
43.05
41.31

4.31
5.29
6.27
8.26

21
21
11
7

43.19
42.33
44.00
45.86

SD
4.35
5.03
5.14
1.86

t(df) and p
/(43) = —l.40.,p = .17
/(43) = -.86, p = .39
f(28) = .42, p = .67
/(18) = 1.90, p = .08

Note. N = Number of Veterans, M - Mean Scores, SD = Standard Deviation, d f =
Degrees o f Freedom.
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Carry forward analyses were also completed with the PDS to address loss of
power due to drop out. Figure 9 presents the mean scores for the PDS for the BA and
comparison groups over the four assessment times after the last data point has been
carried forward.

46
£

s
i
S
Vi

Vi
Q
cu

45
44
43

Comparison
Group
BA Group

42
41
40

i

PreTreatment

-

PostTreatment

- i------------------------------ i

1 Month
Follow-up

2 Month
Follow-up

Assessment Times
Figure 9. Carry Forward PDS Symptom Severity Score Means for the Two Groups
Over the Four Assessment Times.
A two-factor repeated measures analysis of variance was conducted to
examine the differences between groups in change in PDS symptom severity scores
over the four assessment times after carry forward adjustments were completed. Due
to the lack o f sphericity, the time main effect and time x group interaction effect were
tested using the multivariate criterion of Wilks’ lambda. The time main effect was not
significant, Wilks’ lambda = .92, F(3, 41) = 1.18, p = .33, n2 = .08. The time x group
interaction effect was not significant, Wilks’ lambda = .89, F(3, 41) = 1.70, p = .18,
n =.11. The univariate test associated with the between groups main effect was not
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2

significant, F (l, 43) = .19, p = .66, n = .004. The eta squared statistic indicated a
moderate effect size for the time main effect and interaction and a small effect size for
the between groups main effect.
Treatment Outcome With the Mississippi Scale
Figure 10 presents the mean scores for the Mississippi Scale for the BA and
comparison groups across the four assessment times and the dropout groups at
pretreatment. A one-way analysis of variance (ANOVA) was conducted to determine
if there was a significant difference between the mean scores for the comparison
group (A/ = 136.05), BA group (M = 136.29), veterans assigned to the comparison
group who dropped out before posttreatment assessment (M = 126.29), and veterans
assigned to the BA group who dropped out before posttreatment assessment (M=
131.80). The ANOVA was not significant, F(3, 53) = 1.18,/> = .33, indicating that
the Mississippi means for the groups did not differ significantly at pretreatment.
A two-factor repeated measures analysis of variance was completed to
examine the differences between groups in change in Mississippi scores over the four
assessment times. The time main effect was not significant, F(3, 54) = .31, p = .82,
2

n = .02. The time x group interaction effect was not significant, F(3, 54) = 1.35,
2

p = .27, n = .07. The univariate test associated with the between groups main effect
2

was also not significant, F (l, 18) = .Ql,p = .92, n = .001. The eta squared statistic
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Figure 10. Mississippi Scale Total Score Means for the Different Groups Over the
Four Assessment Times.
indicated a small effect size for the time main effect and between groups main effect
and a moderate effect size for the interaction.
Despite the lack of statistical significance using this test and due to the loss of
power from subject drop out, the graphs of means scores were visually inspected and
paired t tests were completed to assess for significant within groups mean changes.
No significant differences were found for either the comparison or BA groups. Four
independent samples t tests were completed to assess for significant differences
between the BA group and comparison group for each of the four assessment times.
No significant differences were found between the comparison and BA groups at any
of the assessment times (see Table 11 for Mississippi score means, standard
deviations, and t test results).
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Table 11
Mississippi Score Means, Standard Deviations, and Independent Samples
t Tests Across the Four Assessment Times
BA Group

Pretreatment
Posttreatment
1-month
2-month

Comparison Group

N

M

SD

N

M

SD

t(df) and/?

24
24
19
13

136.29
138.71
140.37
135.38

14.86
15.04
17.77
19.79

21
21
11
7

136.05
137.33
137.18
142.71

11.80
12.97
12.75
14.84

/(43) = -.06, p = .95
1(43) = -.33,/? = .75
/(28) = -.52, /? = .61
1(18)= .85,/? = 4 0

Note. N = Number of Veterans, M = Mean Scores, SD = Standard Deviation, d f=
Degrees o f Freedom.
Carry forward analyses were also completed with the Mississippi scores to
address loss of power due to drop out. Figure 11 presents the mean scores for the
Mississippi for the BA and comparison groups over the four assessment times after
the last data point has been carried forward.
A two-factor repeated measures analysis of variance was conducted to
examine the differences between groups in change in Mississippi scores over the four
assessment times after carry forward adjustments were completed. Due to the lack of
sphericity, the time main effect and time x group interaction effect were tested using
the multivariate criterion of Wilks’ lambda. The time main effect was not significant,
Wilks’ lambda = .97, F (3,41) = .45, p = .72, n2 = .03. The time x group interaction
effect was not significant, Wilks’ lambda = .88, F(3, 41) = 1.87, p = . 15, n = . 12.
The univariate test associated with the between groups main effect was not
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Figure 11. Carry Forward Mississippi Scale Total Score Means for the Two Groups
Over the Four Assessment Times.

significant, F(l, 43) = .08, p = .78, n = .002. The eta squared statistic indicated a
small effect size for the time main effect and between groups main effect and a
moderate effect size for the interaction.
Multiple Regression Analyses
One goal of the study was to attempt to find factors that would predict change
in depression and PTSD symptoms. A measure of change in depression and PTSD
was calculated by subtracting the 2-month follow-up scores on the BDI-II, RHRSD,
PDS symptom severity, and Mississippi scales from the pretreatment scores.
Predictor variables included in the multiple regression included a CAC subscale
associated with the belief that one is unable to change (unable to change), a CAC
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subscale associated with fear o f the process required for change (fear of change),
MCMI-m base rate scores from the desirability scale (desirability), a difference score
calculated by subtracting M CM I-m base rates of the desirability scale from the
debasement scales (MCMI difference), a difference score calculated by subtracting
percentage of current PTSD service connection from desired PTSD percentage of
service connection (SC change), a current total percentage o f service connection
score (SC), and therapist ratings of homework completion for veterans in the BA
group (homework). These variables were included after they were found to have
significant correlations with depression and PTSD change scores among the four
assessment times across the four psychological tests.
The overall model from the multiple regression completed with the BDI-n
2

change score was not significant, R = .03, F(7, 5 ) = .95, p = .54. This combination
of predictor variables accounted for only 3% of the variance in BDI-II change scores.
No individual predictor provided a significant unique contribution to the model (see
Table 12 for the BDI-II multiple regression Betas, t scores, and significance level for
the variables).
The overall model from the multiple regression completed with the RHRSD
2

change score was significant, R = .87, F (l, 5 ) = 12.89, p = .006. This combination
of predictor variables accounted for 87% of the variance in RHRSD change scores.
Two individual predictor variables provided significant unique contributions to
explaining the RHRSD change score (see Table 13 for the RHRSD multiple
regression Betas, t scores, and significance levels for the variables). Veterans who
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Table 12
BDI-II Change Score Multiple Regression Results for Seven Predictor Variables
Variable

Beta

t

P

Unable to Change
Fear o f Change
Desirability
MCMI Difference
SC Change
SC
Homework

-.17
-.26
1.44
1.40
-.84
-.77
.32

-.34
-.51
1.67
1.58
-1.30
-1.17
1.00

.75
.63
.16
.17
.25
.29
.36

Table 13
RHRSD Change Score Multiple Regression Results
for Seven Predictor Variables
Variable

Beta

t

P

Unable to Change
Fear of Change
Desirability
MCMI Difference
SC Change
SC
Homework

.27
-.54
.06
.31
-.39
-.07
.67

1.54
-3.04
.20
1.01
-1.71
-.33
5.96

.18
.03
.85
.36
.15
.76
.002

had greater change in RHRSD scores had been rated higher in their homework
completion by therapists. Veterans who had greater change in RHRSD scores had
lower scores on the CAC fear of the process of change subscale. These findings are
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significant when controlling for the variance explained by the other variables in the
model.
The overall model from the multiple regression completed with the PDS
2

change score was not significant, R = .23, F(7, 5) = 1.51, p = .34. This combination
o f predictor variables accounted for 23% of the variance in PDS change scores. No
individual predictor provided a significant unique contribution to the model (see Table
14 for the PDS multiple regression Betas, t scores, and significance levels for the
variables).
Table 14
PDS Change Score Multiple Regression Results for Seven Predictor Variables
Variable

Beta

t

P

Unable to Change
Fear of Change
Desirability
MCMI Difference
SC Change
SC
Homework

-.11
-.17
1.53
1.30
-.86
-.96
.25

-.26
-.40
2.06
1.70
-1.53
-1.69
.90

.80
.70
.09
.15
.19
.15
.41

The overall model from the multiple regression completed with the Mississippi
2

change score was not significant, R = .25, F(7, 5 ) = 1.59, p = .32. This combination
o f predictor variables accounted for 25% of the variance in Mississippi change scores.
No individual predictor provided a significant unique contribution to the model (see
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Table IS for the Mississippi multiple regression Betas, t scores, and significance levels
for the variables).
Table IS
Mississippi Change Score Multiple Regression Results
for Seven Predictor Variables
Variable

Beta

t

P

Unable to Change
Fear of Change
Desirability
MCMI Difference
SC Change
SC
Homework

-.78
.45
.92
.93
-.48
-.51
.62

-1.87
1.05
1.26
1.24
-.88
-.91
2.29

.12
.34
.26
.27
.42
.41
.07

Clinical Significance
The RHRSD is a clinician administered rating form that is designed to assess
symptoms associated with depression. Clinical significance was examined using
RHRSD total scores collapsed into four categories. The categories included scores
from 0 to 10 (not depressed), 11 to 16 (minor depression), 17 to 25 (major
depression), and 26 or above (severe depression) (Warren, 1996). A Friedman test
was conducted to evaluate the significant changes in mean ranks from the four
RHRSD diagnostic categories for the BA group at pretreatment (mean rank = 3.04),
posttreatment (mean rank = 2.15), 1-month follow-up (mean rank = 2.92), and 2month follow-up (mean rank = 1.88) and for the comparison group at pretreatment
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(mean rank = 3.19), posttreatment (mean rank = 2.06), 1-month follow-up (mean
rank = 2.S0), and 2-month follow-up (mean rank = 2.25). The test was significant for
2

2

the BA group x (3, N = 13) = 11.41, p - .01, but not for the comparison group x (3,
N = 8) = 5.58, p = .13.
Follow-up comparisons were conducted using Wilcoxon Signed Ranks tests.
There was a significant change in the number of subjects among the four diagnostic
categories in the BA group from pretreatment to posttreatment (p = .001),
posttreatment to 1-month follow-up (p = .046), and 1-month follow-up to 2-month
follow-up (p = Oil) (see Table 16 for the number and percentage of veterans in each
diagnostic category).
Table 16
Number and Percentage of Veterans in Each RHRSD
Diagnostic Category Between Groups
Depression
Category
Not
Minor
Major
Severe

Comparison Group N(%)
Pre

Post

I (5)
11(55)
6(30)
2(10)

9(45)
5(25)
6(30)
0 (0)

1-Month 2-Month
3(21)
4(29)
7(50)
0 (0)

4(50)
2(25)
2(25)
0 (0)

BA Group V(%)
Pre

Post

4(17) 10(42)
7(29) 11(46)
12 (50) 3(12)
1 (4) 0 (0)

1-Month :2-Month
5(26)
7(37)
6(32)
1 (5)

5(39)
6(46)
2(15)
0 (0)

Note. N = Number of Veterans, % = Percentage of Veterans, Pre = Pretreatment,
Post = Posttreatment, 1-Month = 1-Month Follow-up, 2-Month = 2-Month
Follow-up.
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A chi-square test was conducted to assess whether the difference between the
BA group and comparison group in the number of subjects in each diagnostic
category at each assessment time was statistically significant. The results o f these tests
2

were not significant for pretreatment x (3 ,N = 44) = 4.70, p - . 19, posttreatment
x2(2, N = 44) = 2.96, p = .23,1-month follow-up x2(3, N —33) = 1.68,/> = .64, or 22
month follow-up assessment x (2, N = 21) = .98, p = .61.
RHRSD groups were collapsed further and the Wilcoxon Signed Ranks test
was used to assess for significant change. The number of veterans in the comparison
group with no to minor depression increased from pretreatment (60%) to
posttreatment (70%) and 2-month follow-up (75%), with a decrease at 1-month
follow-up (50%). These changes over assessment times were not statistically
significant (ally’s > .05). The number o f veterans in the BA group with no to minor
depression increased significantly from pretreatment (46%) to posttreatment (88%),
p = .002, and from 1-month follow-up (63%) to 2-month follow-up (85%), p = .046.
There was also a significant decrease in the number of subjects in the BA group with
no to minor depression from posttreatment (88%) to 1-month follow-up (63%), p =
.046.
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Additional Analyses
Client Satisfaction With Treatment
The veterans who participated in the BA group completed the Client
Satisfaction Questionnaire (CSQ) (see Table 17 for frequencies of responses to the
questionnaire). The responses from the veterans were generally positive or very
positive. One veteran responded negatively to two of the questions. This might be
attributed to the reverse scoring on the questionnaire since the negative response is
not consistent across most of the questions. The majority of the veterans rated the
quality o f the group as excellent (67%), believed they received the type of group they
wanted (67%), would recommend the group to a friend with a similar problem (83%),
were satisfied with the amount of help received (63%), believed the group helped
with the problem (54%), were overall very satisfied with the group (63%), and would
use the group again (79%). The only item that was not given the highest rating was
regarding the extent to which the group met the veterans’ needs (33%).
Three different therapeutic BA groups were run for this study. A one-way
analysis o f variance (ANOVA) was conducted to determine if there was a significant
difference between the CSQ total scores for the first group (M = 28.55), second
group (M = 28.33), and third group (M = 29.50). The ANOVA was not significant,
F (2 ,21) = .36, p = .70, indicating that the members in the three BA groups did not
differ significantly in their satisfaction with the group.
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Table 17
Number and Percentage o f Responses for Each Question on the CSQ
Content

Responses

Quality of Group

Excellent
16 (67%)

Good
8 (33%)

Fair
0 (0%)

Poor
0(0%)

Service Wanted

Yes
16 (67%)

Generally
8 (33%)

Not Really
0 (0%)

No
0 (0%)

Almost All
8 (33%)

Most
14 (59%)

A Few
2 (8%)

None
0 (0%)

Yes
20 (83%)

Probably
4(17%)

Probably Not
0 (0%)

No
0 (0%)

Very Satisfied
15 (63%)

Satisfied
8 (33%)

Indifferent
0 (0%)

Dissatisfied
1 (4%)

Met Needs
Recommend to Friend
Amount of Help

Not Really Made Worse
0 (0%)
0(0%)

Helped with Problem

Yes
13 (54%)

Somewhat
11(46%)

Overall Satisfaction

Very
15 (63%)

Mostly
8 (33%)

Indifferent
0 (0%)

Use Group Again

Yes
19 (79%)

Maybe
5 (21%)

Probably Not
No
0 (0%)
0(0%)

Dissatisfied
1 (4%)

Note. Responses and content listed have been shortened from actual responses and
content on questionnaire.
BA Group Cohort Equivalence
Three separate group cohorts were provided the BA treatment. One-way
analysis of variances (ANOVA) were conducted on the BDI-II, RHRSD, PDS, and
Mississippi scales at the pretreatment, posttreatment, and 1-month follow-up to
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determine if there were significant differences between the three group cohorts. One
o f the group cohorts had only one veteran who completed the 2-month follow-up, so
independent samples t tests were conducted on the four scales at this assessment time
on the other two cohorts. No significant differences were found (see Table 18 for
results o f ANOVAs and / tests).
Table 18
Results From One-Way ANOVAs for the Four Tests at Pretreatment, Posttreatment,
and 1-Month Follow-up for the Three Group Cohorts and t Tests
at the 2-Month Follow-up for Two of the Group Cohorts
Pretreatment
F

Test
BDI-n
RHRSD
PDS
Mississippi

.64
2.18
1.31
.85

P
.54
.14
.29
.44

Posttreatment

1-Month

2-Month

F

P

F

P

t

P

2.11
1.51
.37
1.34

.54
.24
.70
.28

2.55
2.03
.90
2.92

.11
.16
.42
.08

1.80
1.51
1.12
1.93

.10
.16
.29
.08

Note. 1-Month = 1-month follow-up, 2-Month = 2-month follow-up. Degrees of
Freedom at Pretreatment (2, 21), Posttreatment (2, 21), 1-Month Follow-up (2, 16),
and 2-Month Follow-up (10).
Therapist Equivalence
Two of the groups were facilitated by a psychology intern and one of the
groups was facilitated by a staff psychologist. To assess for significant differences
among veterans’ BDI-II, RHRSD, PDS, and Mississippi scores between the two
therapists, independent samples t tests were conducted for each of the four
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assessment times. No significant differences were found (see Table 19 for results of t
tests to assess for significant differences in test scores across the assessment times
between the two therapists).
Table 19
Results From t Tests Between the Two Group Therapists
for the Four Tests at the Four Assessment Times
Pretreatment

1-Month

2-Month

t

P

t

P

t

P

t

P

.99
-.29
1.55
.15

.33
.77
.13
.88

1.87
0
.43
.88

.07
1.00
.67
.39

1.42
1.04
1.05
.86

.17
.31
.31
.40

.86
.60
.30
.67

.41
.56
.77
.51

Test
BDI-II
RHRSD
PDS
Mississippi

Posttreatment

Note. 1-Month = 1-month follow-up, 2-Month = 2-month follow-up. Degrees of
Freedom at Pretreatment (22), Posttreatment (22), 1-Month Follow-up (17), and 2Month Follow-u p (11).
Process Measures
The BDI-H was used as a process measure during the BA group treatment
and was administered to the veterans during sessions 2,4,6, and 8. A two-factor
repeated measures analysis of variance was completed to examine the differences
between the three group cohorts in change in BDI-II scores over the four assessment
times. The time main effect was significant, F(3, 48) = 10.16 , p < .0005. The time x
group interaction effect was not significant, F(6, 48) = 1.67, p = .15. The
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univariate test associated with the between-groups main effect was also not
significant, F(2, 15) = 3.17, p = .07.
Three one-way repeated-measures analysis of variance tests were conducted
to examine the significant time main effect for each of the group cohorts. The results
for the first group cohort, F{3, 21) = 1.56, p = .23, and second group cohort were not
significant, F(3, 9) = 3.16, p = .08. The results for the third group cohort were
significant, F(3, 18) = 6.54, p = .003.
Six paired t tests were completed to follow up the significant results for the
third group cohort. Bonferroni adjustments of alpha levels were used to control for
inflated type 1 error. Differences in mean BDI-H scores across assessment times for
the third group cohort were significantly different between session 2 and session 4,
f(6) = 5.40,p = .002, and session 2 and session 6, /(6) = 3.89, p = .008. Differences
between session 2 and session 8, /(6) = 3.15, p = .02, session 4 and session 6, r(6) =
-1.34, p = .23, session 4 and session 8, t(6) = .65, p = .54, and session 6 and session
8, J(6) = 1.67, p = .14 were not significant after applying the Bonferroni adjustments
of alpha levels. The third group cohort’s BDI-II scores decreased significantly from
the second session to the fourth session and from the second session to the sixth
session.
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CHAPTER IV
DISCUSSION
Purpose of the Study
The purpose of this study was to examine the effectiveness of the BA group
treatment in reducing psychological symptoms associated with depression and PTSD
for an inpatient population o f combat veterans. The study also explored for the
presence of variables that may be predictive of changes in symptoms as measured by
psychological assessments o f depression and PTSD. Finally, the study examined the
clinical significance of the observed outcomes.
Population Characteristics
Consistent with previous research examining comorbid PTSD and depression
(Blanchard et al., 1998; Southwick et al., 1991), the veterans in this study evidenced
many symptoms related to elevated psychological, personal, and social dysfunction
and distress. Veterans’ scores on the MCMI-m exceeded scores associated with
significant problematic personality characteristics on half of the scales, including
scales associated with PTSD and depression. Veterans’ ratings of objective and
subjective measures of quality of life on the ComQol were consistently low, with very
noticeable differences from a norm group on subjective perception of quality o f life.
All o f the veterans met diagnostic criteria for PTSD using the PDS. A majority o f the
78
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veterans (89%) were assessed by clinicians with the RHRSD as having at least minor
depression. Almost all of the veterans were taking medication for depression (96%)
and a majority were taking medications for anxiety (73%). A majority of the veterans
(76%) were seeking disability compensation for PSTD.
Treatment Outcomes for Depression
Results from self-report depression inventories showed no or very mild
changes and remained elevated throughout all four assessments. BDI-H scores for
veterans in the BA group reduced significantly from pretreatment to posttreatment.
BDI-H scores for the comparison group evidenced a small increase from pretreatment
to posttreatment, which was not significant. Despite this difference in results, the
mean BDI-H scores for the two groups did not differ significantly at posttreatment.
Both groups also continued to score within the severe depression range on the BDI-H
(Beck et al., 1996) at the posttreatment assessment. Although the BA group did not
show any other statistically significant changes in BDI-H scores, the comparison
group continued to evidence an increase in depression symptoms, which reached
statistical significance from the one-month follow-up to the two-month follow-up.
The carry forward analysis of the BDI-H indicated that the change in scores between
pretreatment to posttreatment was significantly different between the two groups,
with the treatment group reporting a greater reduction of symptoms between the two
assessment times than the comparison group. No significant differences across
assessment times or between the two groups were found using the BHS, except at the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

80
two-month follow-up. The comparison group scored significantly higher than the BA
group at the two-month follow-up on the BHS.
The effectiveness of the BA group for this population, as assessed by the BDIII, is not as promising as results from the Porter (2000) BA group treatment study
with outpatients. One potential explanation for these differences is that the BA group
in the present study included 8 group sessions over a 4-week period as opposed to 10
sessions once a week in the Porter study. The reduction of time in therapy may have
resulted in less change among subjects. The shorter period of time encompassing the
whole process of treatment may also have led to reduced change.
Another potential explanation is that the subjects in the present study were
inpatients as opposed to the Porter examination of treatment effectiveness for
outpatient subjects. The subjects in the present study were all also diagnosed with,
and were seeking treatment primarily for, chronic PTSD in addition to having
symptoms associated with depression. The Porter study worked with subjects who
were seeking treatment for depression. Comorbid diagnoses were not reported in the
Porter study. Therefore, as suggested by previous research (Blanchard et al., 1998;
Southwick et al., 1991), the current population may have been more psychologically
impaired than the Porter subjects.
Results from the clinician-administered scale (RHRSD) were more promising.
Symptoms of depression decreased significantly from pretreatment to posttreatment,
pretreatment to two-month follow-up, and one-month follow-up to two-month
follow-up for the BA group. While a similar pattern of symptom change across
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assessment times was seen with the comparison group, none of the changes were
statistically significantly. The differences between the two groups at each of the
assessment times were also not statistically significant. For the BA group, the mean
score decreased from the major depression range to the minor depression range and
almost reached the not depressed range by the two-month follow-up. The comparison
group mean remained in the minor depression range throughout the four assessment
times.
Overall, these results indicate that those subjects receiving the BA treatment
had a statistically significant reduction in self-reported depressive symptoms from the
pretreatment to posttreatment assessment times, while the comparison group did not.
Clinician ratings of depression indicated additional statistically significant changes in
symptoms of depression for BA group participants from the one-month follow up to
the two-month follow-up. Changes on the BDI and RHRSD for the comparison
group did not show statistically significant change. In fact, the comparison group
evidenced a trend towards experiencing more symptoms of depression measured with
self-report inventories across the four assessment times, although the only statistically
significant change was an increase in symptoms measured by the BHS from onemonth to two-month follow-up.
Treatment Outcomes for PTSD
No statistically significant changes in symptoms across assessment times were
found for either the PDS or Mississippi scale. There were also no statistically
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significant differences in scores on the PDS or Mississippi between the groups at any
o f the assessment times. These results did not seem to be related to decreased power
due to subject drop out, since no significant results were found using the carry
forward analyses. One potential point of consideration is that the psychological tests
used to assess PTSD were both self-report. No clinician-administered assessments
were used. Another consideration is the fact that this population is reporting PTSD
symptoms associated with traumas that usually happened almost 30 years ago,
indicating the presence of very chronic and potentially change-resistant psychological
problems. This failure of treatment to reduce self-reported PTSD symptoms is
consistent with previous research (Fontana & Rosenheck, 1997; Johnson et al., 1996;
Ruzek et al., 2001; Shalev, 1997).
Treatment Outcome Considerations
Changes in outcome scores for the BA group were not differentially affected
by differences in the three BA group cohorts. Changes in outcome scores for the BA
group were also not differentially affected by who the therapist was for the group.
The group cohorts and therapists were statistically equivalent as assessed by outcome
scores.
Results from the MCMI-m on the desirability and debasement modifying
indices suggest that the veterans in this study may have a tendency to exaggerate
current symptoms (Millon et al., 1997). This may provide an explanation for the
differences in symptoms when assessed with the self-report tests versus therapist-
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administered scale in this study. This explanation needs to be counterbalanced with
therapist expectancies of treatment effectiveness. Because all of the veterans received
treatment in the residential PTSD program, the therapists may have been more likely
to report positive change as a function of knowing the veterans received treatment.
The “true” measure of treatment effect may lie somewhere between these two.
A potentially interesting observation from the data is that scores for veterans
in the comparison group on the BDI-H, BHS, and PDS tended to consistently
increase over the four assessment times, while scores for the BA group did not (see
Figures 2, 4, and 8). Although the differences between the groups were not
statistically significant, a potential hypothesis for these trends is that the BA
therapeutic group may have mildly moderated symptoms or reporting of symptoms.
These trends are also seen when the carry forward procedure was applied (see Figures
3, S, and 9). Similar results using a “second generation” type of treatment were also
found by Fontana and Rosenheck (1997) and Johnson and his colleagues (Johnson &
Lubin, 1997; Johnson et al., 1997). These researchers suggest that veterans may
benefit from a change in focus of treatment from trauma-specific symptoms to socialfunctioning problems. The BA treatment would seem to be a good example of
intervention aimed to address social-functioning problems.
Another pattern that emerges upon examination of group means is a decrease
in symptoms from pretreatment to posttreatment, an increase in symptoms from
posttreatment to one-month follow-up, and a decrease in symptoms from one-month
follow-up to two-month follow-up for the BA group on the BDI-II and RHRSD. This
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pattern is also seen for the comparison group on the RHRSD. This “depression
relapse” at the one-month follow-up was not reported in previous studies (Jacobson
et al., 1996; Porter, 2000), but these studies completed three- and six-month followups, respectively, rather than a one-month follow-up. One of the therapists from the
PTSD residential program (W. Bloem, personal communication, October 2, 2002)
shared that this is consistent with clinical observations of this patient population. A
potential hypothesis discussed was that veterans with chronic psychological
complaints going from a structured living situation while in treatment to an
unstructured situation upon discharge have difficulty readjusting. Another hypothesis
was that the treatment in the program involves the recall of traumatic experiences,
resulting in an increase in clinical symptoms once the subjects are no longer in what
they consider a safe or controlled environment.
Variables Predicting Treatment Outcomes
The multiple regression analysis was completed to assess for variables that
may predict response to treatment. The combination of predictor variables making up
the model accounted for 87% of the variance in depression change scores on the
RHRSD. Two variables provided unique contributions to explaining change in
RHRSD scores. The largest contribution was from therapist ratings of homework
completion for veterans in the BA group. More work by veterans on assignments
outside the therapy session was associated with greater reductions in RHRSD scores.
The other variable that provided a unique contribution to the model was the fear of

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

85
the process of change subscale on the CAC. Higher scores, indicating greater fear of
the process of change, were associated with smaller reductions in RHRSD scores.
The results for the overall models for the BDI-II, PDS, and Mississippi Scale were
not significant and accounted for 3%, 23%, and 25% of the variance in depression
and PTSD change scores, respectively.
The effort patients put into completing assignments outside of the therapy
sessions in treatment may be indicators of motivation for, and commitment to
engaging in behaviors that may help relieve some of the difficulties they face (Beck et
al., 1979). The results from this study indicate that the amount of effort veterans put
into homework assignments will be predictive of a reduction of therapist ratings of
depression. Encouraging homework assignments may be an important therapeutic
tool in helping veterans become more engaged in the therapeutic process.
The fear of the process of change subscale on the CAC included questions
about change being too painful to bear, change making one’s life more difficult,
change causing suffering, change making one feel worse than he already does, change
requiring too much effort, and change involving facing tasks that would be too
unpleasant. The results of this study indicate that veterans who are more afraid of the
processes associated with the changes needed to experience relief from psychological
distress will not experience as much reduction in depressive symptoms as those not
afraid of these processes. These findings suggest that therapists may enhance
therapeutic response by educating veterans about the processes necessary to initiate
change and using techniques to help reduce fears about the change process.
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Clinical Significance
Clinical significance in this study was assessed by examining changes in
RHRSD scores after the scores were collapsed into four different levels of depression
identified by Warren (1996). For this study, there was a statistically significant
increase in the number of members from the BA group who fell into the “not
depressed to minor depression” range of scores from pretreatment to posttreatment.
As discussed earlier, there was a significant “relapse in depression” from
posttreatment to one-month follow-up for the BA group, followed by another
significant reduction in veterans falling into these categories from one-month followup to two-month follow-up. While less than 50% of the veterans in the BA group
were rated by therapists as having no to minor depression at pretreatment, 63% to
88% of this group where rated as having no to minor depression at each of the three
remaining assessment times. No significant changes were seen across times for the
comparison group, although 50% or more of the members in this group fell in the no
to minor depression range at each assessment time.
Client Satisfaction
Veterans participating in the BA group treatment were very satisfied with the
group. With the exception o f two individual item responses on the CSQ, all responses
were within the satisfied to very satisfied range. The group was so well received that
the staff implemented the group as a regular part of the schedule for the program after
the study was completed. Another anecdotal indication of the satisfaction with the
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group was that a few o f the veterans who were in the program while the BA group
was going, but declined to participate in the study, asked to participate in the group
after talking with veterans participating in the study who had attended a few o f the
groups.
Limitations of the Study
A major limitation in this study was the lack of experimental control. The
study was conducted in a clinical setting within a Veterans Affairs Medical Center,
which restricted the ability to implement more stringent experimental procedures such
as random assignment to groups, taping of groups for treatment integrity checks,
reducing patient dropout over follow-up assessments, or standardization of
concurrent treatment. The reduction in variance between subjects by more
discriminating selection may have helped more clearly identify differences between the
two groups. The significant drop out of patients at the follow-up assessments also
resulted in decreased power and decreased ability to identify maintenance o f treatment
effect.
The use of a standard treatment comparison group may also have been a
limitation for this study. Since both comparison and BA groups were receiving some
type of treatment, the differences in treatment effect were probably diminished. In
addition, the fact that a concurrent treatment was occurring with the BA group
contributes a confounding variable to identifying outcome associated with the BA
treatment. However, a stated purpose for this study was the examination of the
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effectiveness of BA treatment for an inpatient population often found to experience
comorbid depression, so this confounding variable was likely unavoidable. Perhaps a
larger number of subjects would have helped to identify more clearly the effect
attributable to the BA treatment.
All of the veterans were diagnosed with chronic PTSD to the level of being
considered appropriate for inpatient or residential treatment. This appeared to result
in a limitation associated with the assessments used to assess PTSD. A ceiling effect
was observed in that most of the veterans reported the maximum, or near maximum,
number of symptoms associated with PTSD. Assessment devices that help
differentiate PTSD levels among people with chronic PTSD may have been more
useful in identifying change in PTSD associated with not only the BA treatment, but
also the treatment offered in the program.
Finally, a limitation in this study was the failure to identify potential
confounding effects of variables associated with secondary gain. The majority of
subjects in the study were interested in, or were seeking, increases in compensation
for problems associated with PTSD. The CAC was used to try to distinguish between
veterans who may have been seeking treatment for personal change and those who
may have been seeking treatment for secondary gain. Subjects interested primarily in
secondary gain would be hypothesized to report less personal change on outcome
measures. The CAC did not effectively differentiate these groups. Psychological tests
that are more successful in identifying patients with secondary gain issues that serve
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as the primary motivators for seeking treatment may be helpful in further parceling
out variance in this group and identifying treatment effect.
Future Research
In the current study, the BA group consisted o f eight group sessions over 4
weeks. This was not consistent with the number of, or time between, sessions in the
Porter (2000) group study or Jacobson et al. (1996) individual therapy study of the
BA treatment. Since the results found in this study were limited, a study with more
treatment groups spread over a longer time period may provide additional insight into
the effectiveness of BA treatment with this population.
As discussed earlier, research using more sensitive assessment devices may be
valuable. Tests that are more sensitive to PTSD change in an already diagnosable
population may provide a better understanding of treatment effects. Inventories that
help to differentiate various groups in relation to secondary gain issues may increase
understanding of the therapeutic benefits. The use of therapist-administered
assessments of PTSD may be helpful in more clearly identifying change when working
with this population. Many of these tests do not yet exist, or were not identified
during the development of this project, so research developing such assessment tools
would also be helpful.
Finally, the Battle Creek Medical Center also has an outpatient program
specifically for veterans with PTSD. The outpatient program generally utilizes the
same staff as the inpatient program. The BA group could be provided to outpatient
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veterans and the relative effectiveness of the treatment between an outpatient and
residential population could be explored. Likewise, changes in session numbers and
length of treatments would be more easily explored in an outpatient setting and may
provide additional information in regards to the most efficient and effective provision
of the BA treatment.
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Human Subjects Institutional Review Board

Kalamazoo. Michigan 49008-5456
616 387-8293

W e s t e r n M i c h i g a n U n iv e r s it y

Date:

15 December 2000

To:

C. Richard Spates, Principal Investigator
Theodore Wright, Student Investigator for dissertation

From: Michael S. Pritchard, Interim Chair
Re:

HSIRB Project Number 00-10-27

This letter will serve as confirmation that your research project entitled “Depression and
Combat-Related PTSD” has been approved under the full category o f review by the
Human Subjects Institutional Review Board. The conditions and duration o f this
approval are specified in the Policies o f Western Michigan University. You may now
begin to implement the research as described in the application.
Please note that you may only conduct this research exactly in the form it was approved.
You must seek specific board approval for any changes in this project. You must also
seek reapproval if the project extends beyond the termination date noted below. In
addition if there are any unanticipated adverse reactions or unanticipated events
associated with the conduct of this research, you should immediately suspend the project
and contact the Chair o f the HSIRB for consultation.
The Board wishes you success in the pursuit o f your research goals.

Approval Termination:

15 December 2001
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Department of
Veterans Affairs
t* *
F ro m :

Memorandum

JAN S C 2001
Medical Center Director (515/142)

s*** Protocol Recommendation and Approval
To Theodore Wright, M.A. (116B)

1. Your protocol, “Depression and Combat-Related PTSD”, has been reviewed and recommended
for approval by the Research and Development Committee and Clinical Executive Board. This
protocol has received my approval and you may commence your study at Battle Creek VA Medical
Center.
2. Any changes you may wish to make to the protocol must receive approval upon review by the
Research and Development Committee before initiation. In addition, any publications or
presentations resulting from this protocol must receive my approval prior to submission. You
should submit such a presentation or publication to Ellie Pettee or Cheryl Thrum to initiate a
review.
3. Please submit monthly a list o f all patients enrolled to Cheryl Thrum, Chairperson,
Subcommittee on Human Studies (118). Signed Consent Forms should be submitted to her as they
are obtained. In addition, please submit a quarterly report to Ellie Pettec to include the number of
subjects enrolled, any subjects who have withdrawn, any complaints or adverse events involving
subjects, findings so far (and/or a conclusion o f the study), any changes or amendments since the
last review, any publications or presentations since the last review and the expected date of
completion. Due dates for this quarterly report for your study are: March 31, June 30, September
30 and December 31, 2001.
4. If you have any questions regarding this protocol, please contact Elinor J. Pettee, RNC, MSN,
Coordinator for Research and Development at Ext. 6426 or Suzanne Thome-Odem, RN, MS,
Chairperson, Research and Development Committee at Ext. 3414.

VA FORM 210S Automated
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BA Group Recruitment Script
[Introduce yourself if necessary] I would like to talk briefly about a research study
being conducted here on the ward with members of the R-track.
The study is for combat veterans who are struggling with symptoms often
related to traumas such as problems with anger or depression, fear of or efforts to
avoid situations or people that remind him of traumas, intrusive memories or thoughts
regarding traumas, nightmares or flashbacks related to traumas, feelings of numbness
or isolation, being constantly “on edge” or unable to relax, or problems with sleep or
concentration. This study is a treatment study, so participants will be attending a
group designed to reduce some of the problems a combat veteran may be
experiencing. It includes filling out several questionnaires, in addition to receiving
treatment. The study includes 4 sessions in which questionnaires are completed and
up to 8 group treatment sessions that will last one and a half to two hours.
If you are interested in participating or would like to learn more about the
study, please tell me and I will contact Ted Wright. He will meet with you on the
ward to answer questions and have you sign a consent form if you decide to continue.
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Comparison Group Recruitment Scrint
[Introduce yourself if necessary] I would like to talk briefly about a research study
being conducted here on the ward with members of the R-track.
The study is for combat veterans who are struggling with symptoms often
related to traumas such as problems with anger or depression, fear of or efforts to
avoid situations or people that remind him of traumas, intrusive memories or thoughts
regarding traumas, nightmares or flashbacks related to traumas, feelings of numbness
or isolation, being constantly “on edge” or unable to relax, or problems with sleep or
concentration. Participants in this study will be attending up 4 sessions in which he
would complete several questionnaires.
If you are interested in participating or would like to learn more about the
study, please tell me and I will contact Ted Wright. He will meet with you on the
ward to answer questions and have you sign a consent form if you decide to continue.
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BA Group Informed Consent Meeting Script
Hi, my name is _____________ and I was told you may be interested in participating
in a study for R-track members on the ward. This research study is examining
symptoms commonly experienced after trauma such as problems with anger or
depression, fear of people or situations that remind you of the trauma, intrusive
memories or thoughts regarding the trauma, nightmares or flashbacks related to the
trauma, feelings of numbness or isolation, being constantly “on edge” or unable to
relax, problems with sleep or concentration, or engaging in efforts to avoid situations
that remind you of the trauma. The study involves attending up to 4 sessions in which
you will be asked to complete several questionnaires. You will also be offered up to
8 group treatment sessions that may help reduce some o f the symptoms you may be
experiencing. Sessions last between I and 2 hours. The treatment does require you
attend a group with other members of the R-track and complete some tasks outside of
the group while you are on the ward. This may make you uncomfortable, but there
will be a trained therapist who will help you through the therapy process. Do you
have any specific questions that I could answer for you? Are you still interested in
participating? Thank you for your time.
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Comparison Group Informed Consent Meeting Script
Hi, my name is_____________ and I was told you may be interested in participating
in a study for R-track members on the ward. This research study is examining
symptoms commonly experienced after trauma such as problems with anger or
depression, fear of people or situations that remind you of the trauma, intrusive
memories or thoughts regarding the trauma, nightmares or flashbacks related to the
trauma, feelings of numbness or isolation, being constantly “on edge” or unable to
relax, problems with sleep or concentration, or engaging in efforts to avoid situations
that remind you of the trauma. The study involves attending up to 4 sessions in wliich
you will be asked to complete several questionnaires. Answering some o f the
questions may make you uncomfortable, but there will be a trained staff to help if you
have any problems. Do you have any specific questions that I could answer for you?
Are you still interested in participating? Thank you for your time.
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VA RESEARCH CONSENT FORM
Date:

D epression and Combat-Related PTSD

Principal Investigator W illiam Bloem. Ph.D.

VAMC: Battle Creek 515

DESCRIPTION OF RESEARCH BY INVESTIGATOR
NOTE: The consent form should Include the following section headings:
1.
2.
3.
4.
5.
6.
7.
8.
8.

Puipose of study and how long It win last:
Description of the study including procedures to be used;
Description of any procedures that may result In discomfort or inconvenience:
Expected risks or study:
Expected benefits of study:
Other treatment available:
Use of research results:
Special circumstances:
Research subjects' rights:

Participation in an Investigation
Battle Creek Veterans Affairs Medical Center & Western Michigan University
Department o f Psychology
Depression and Combat-Related PTSD
Battle Creek VAMC Principle Investigator William Bloem, Ph.D.,
Battle Creek VAMC Student Investigator Jason DeViva, M.A.
Battle Creek VAMC & Western Michigan University Student Investigator Theodore P. Wright, M.A.
Western Michigan University Principle Investigator C. Richard Spates, Ph.D.
1. Purpose:
I have been invited to participate in a research project entitled “Depression and Combat-Related
PTSD.” This research is intended to study how effective a group treatment is in reducing problems
people often experience after combat trauma. This research may help to provide an additional treatment
for men being treated for combat-related PTSD. The information collected from this study will be used
for Theodore Wright’s dissertation project. The study will include 60 patients and will include 8 group
treatment sessions and 4 assessment sessions. Overall, participation in the study will require
approximately 24 hours o f my time.

Participants Initials.
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Subject Name:

______________________________

Date:

Title of Studv: Depression and Caitoat-Related PTSD
Principal Investigator,

VAMC: Battle Creek 51S

w illia m Bloem, Ph.D._______

(Continuation Page
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2. Procedure:
The procedure for this study is that I will be asked to meet with a psychology staff person at the
Battie Creek VA Medical Center (BCVAMC) to complete several questionnaires before and after the
treatment sessions. The following is a description o f the questionnaires to be used.
a. The Demographic Questionnaire asks questions about my age, family, race, income, military
service, service connection, prior treatments, medications, and driving distance.
b. The Millon Clinical Multiaxial Inventory includes questions related to psychological symptoms
people sometimes experience.
c. The Computerized Diagnostic Interview Schedule includes questions related to psychological
symptoms people sometimes experience related to depression.
d. The Beck Depression Inventory-ll consists of items about feeling depressed and inactive.
c. The Beck Hopelessness Scale asks questions about my view o f the fUturc.
f. The Posttraumatic Stress Diagnosis Scale evaluates the presence and severity of symptoms often
experienced after a trauma.
g. The Mississippi Scale measures the level or severity o f symptoms sometimes related to combat
experience.
h. The Modified Concerns about Change Scale evaluates the possible consequences a person feels
he may experience due to changing behaviors.
i. The Quality o f Life Scale includes questions regarding how happy a person is with his life.
j. The Revised Hamilton Rating Scale for Depression is completed by the therapist and identifies
problems a person may have related to feeling sad and depressed.
k. Client Satisfaction Questionnaire evaluates how happy a person is with the treatment he has
received.
I will also be asked to attend up to 8 group therapy sessions. Sessions will be held 2-3 times a week
for 1.5 to 2 hours. During the treatment sessions I will be asked to discuss personal information, talk about
my daily activities, and give feedback to other group members about their progress. I will be asked to
complete the Beck Depression Inventory every other session. 1 will also be asked to complete assignments
outside the group therapy session. Two o f the assessment sessions and all 8 o f the treatment sessions will be
completed during the time 1am admitted to Ward 12. I will be asked to return to the VA to complete 2 rao-e
assessment sessions 30 and 60 days after my discharge.
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3. Procedures that may result in discomfort or inconvenience:
I may experience psychological and emotional discomfort during sessions as I interact with other
group members and share personal information about myself. I may become uncomfortable between
sessions when 1 am working on assignments. In addition, I will also be asked to complete the questionnaire
which will take up to 2-3 hours. I will be asked to complete the questionnaires right before starting the group
and right after completing the group. I will also be asked to return to the VA and complete some of the
questionnaires 30 and 60 days after I am discharged from Ward 12.
4. Expected risks of the study:
One potential risk o f my participation in this project is that I may become emotionally upset while
participating in the group. However, trained therapists are prepared to terminate the treatment session and
provide crisis counseling should I become significantly upset and s/he is prepared to make a referral if I need
further counseling. I will also be discussing pertinent issues in a group setting. Although no assurances can
be given, all group members will be expected to maintain confidentiality, that is, to not discuss another group
member’s information outside o f the group. If an accidental injury occurs, appropriate emergency measures
will be taken; however, no compensation or additional treatment will be made available to me by Western
Michigan University except as otherwise stated in this consent form.

i

5. Expected benefits of the study:
One way in which I may benefit from this study is that symptoms I have experienced since the
traumas may be reduced. Different components o f the treatment have been shown to be helpful in reducing
symptoms experienced by people who have been traumatized. The knowledge gained from this research
may also help others who have been traumatized and experience depression. Once the study is completed, I
may receive a general summary o f the results if I so wish.
6. Other treatment available:
If it is found that this treatment is not appropriate for me, I will be provided with alternative treatment
options, including services offered at the BCVAMC. If I continue to have difficulties after the 8th treatment
session, my therapist and I will discuss continued treatment options. 1 will continue to receive inpatient
treatment on ward 12 and in the outpatient PTSD clinic for PTSD-rclated problems. I will be responsible for
the cost o f therapy if I choose to pursue it outside the BCVAMC. By participating in this study, I will be in
the group 2-4 hours a week. Ifl were not in the group, I would have this 2-4 hours to myself and would not
be scheduled for any other class, group, or activity.
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7. Use o f the research results:
All the information collected from me is confidential, with the exception o f information regarding
intent to harm oneself or another person or reports o f abuse or neglect to children or vulnerable adults.
These specific incidents, as well as any other information requiring disclosure in order to protect others from
serious harm or the potential for serious harm, require disclosure to the appropriate person and/or authorities.
Information relevant to my continued treatment al this hospital may be included in my hospital file, which is
guarded from access by anyone outside the VA system and is only available to authorized VA personnel. All
other data will be coded and will not contain identifying information. A master list will be kept which
includes names and respective codes. Once the data are collected and analyzed, the master list will be
destroyed. All forms not included in my medical chart will be retained for a minimum o f five years in a
locked file at the BCVAMC. The results o f this study may be published, but my identity and records will
remain confidential. All results used in publication will be reported as group data with no individual
identification. My individual results will not be revealed unless required by law.
8. Special circumstances:
Since I am a veteran-subject, I will normally not be required to pay for treatment received as a subject
in a VA research program, but may be subject to copayment if I fall within the “discretionary work load”
category and meet the means test I will receive medical care and treatment for injuries suffered as a result
of participation in a VA research program in accordance with Federal law. My participation in this research
project, and any information documented in my medical records as a result of my participation in this
research project, may not necessarily have a beneficial effect on any claim for monetary compensation from
the Government, nor does my participation in this research project necessarily entitle me to monetary
compensation for any such claim. Staff members and research personnel may share information relevant to
my treatment on the Ward and in the study if it becomes necessary, such as if I begin to report suicidal
ideation or psychotic symptoms. Information shared between Ward staff and the researchers will be treated
as confidential, consistent with Medical Center policies. If I have any questions or concerns regarding my
consent to participate in the present study, I may contact the Chairperson of the BCVAMC Subcommittee on
Human Studies, Cheryl Thrum at (616) 966-5600, extension 3551. I may also contact the Western Michigan
University Chair, Human Subjects Institutional Review Board (387-8293) or the Vice President for Research
(387-8298) if questions or problems arise during the course o f the study.
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9. Research subjects’ rights:
My signature below indicates that I have read and/or had read to me all o f the above.
'_________________ has explained the study to me and answered all of my questions. I have been told
o f the risks or discomforts and possible benefits o f the study. I have been told o f other choices o f treatment
available to me.
I do not have to take part in this study, and my refusal to participate will involve no penalty o r loss o f
rights to which I am entitled. I may refuse to participate or quit at any time during the study without
prejudice, penalty, or risk o f any loss o f service I would otherwise have and without penalty or loss o f VA or
other benefits to which I am entitled. The results o f this study may be published, but my records will not be
revealed unless required by law. If I have any questions or concerns about this study, I may call the
BCVAMC and contact Dr. William Bloem at (616)966-5600 extension 5344 or Western Michigan
University and contact Dr. C. Richard Spates at (616)387-4329. I can also call Theodore Wright at
(616)323-8307.
In case there are medical problems or questions, 1have been told 1 can call Dr. Bloem at extension
5344 during the day or contact him through extension 0 after hours. If any medical problems occur in .
connection with this study, the VA will provide emergency care. My rights as a research subject have been
explained to me and I voluntarily consent to participate in this study. How and why this study is being
completed has been explained to me. I will receive a signed copy o f this consent form to keep in my
personal records. Signature o f Subject’s Representative is only required if subject is not competent
This consent document has been approved for use for one year by the Western Michigan University
Human Subjects Institutional Review Board (HSIRB) as indicated by the stamped date and signature o f the
board chair in the upper right comer o f each page. Panicipants should not sign this document if the comer
does not show a stamped date and signature.

Subject’s Signature

Date

. Signature o f Subject’s Representative
Signature o f Witness

Witness (print)

Signature o f Investigator
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VA RESEARCH CONSENT FORM
Date:

Siiiject Name:
Title of Study:

Depression and Combac-Relaced PTSD
VAMC: Battle Creek S1S

Principal Investigator: J ill Liam
DESCRIPTION OF RESEARCH BY INVESTIGATOR
NOTE; The consent form should include the following section headings:
1.
2.
3.
4.
5.
6.
7.
8.
9.

Purpose of study and how long It will last:
Description of the study Including procedures to be used;
Description of any procedures that may result In discomfort or inconvenience:
Expected risks of study:
Expected benefits of study:
Other treatment available:
Use of research results:
Special circumstances:
Research subjects' rights:

Participation in an Investigation
Battle Creek Veterans Affairs Medical Center & Western Michigan University
Department of Psychology
Depression and Combat-Related PTSD
Battle Creek VAMC Principle Investigator William Bloem, Ph.D.,
Battle Creek VAMC Student Investigator Jason DeViva, M.A.
Battle Creek VAMC & Western Michigan University Student Investigator Theodore P. Wright, M.A.
Western Michigan University Principle Investigator C. Richard Spates, Ph.D.
1. Purpose:

I have been invited to participate in a research project entitled “Depression and Combat-Related
PTSD.” This research is intended to examine whether depressive symptoms are reduced from attending a
specialized Inpatient PSTD Program for combat veterans. This research may help to identify the need for
additional treatment for men being treated for combat-related PTSD. The information collected from this
study will be used for Theodore Wright’s dissertation project. The study will include 60 patients and will
include 4 assessment sessions.

Participants Initials.
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2. Procedure:
The procedure for this study is that I will be asked to meet with a psychology staff person at the
Battle Creek VA Medical Center (BCVAMC) to complete several questionnaires before and after
attending the R-track at the Battle Creek VAMC. The following is a description o f the questionnaires to
be used.
a. The Demographic Questionnaire asks questions about my age, family, race, income, military
service, service connection, prior treatments, medications, and driving distance.
b. The Millon Clinical Multiaxial Inventory includes questions related to psychological
symptoms people sometimes experience.
c. The Computerized Diagnostic Interview Schedule includes questions related to psychological
symptoms people sometimes experience related to depression.
d. The Beck Depression Inventory-II consists o f items about feeling depressed and inactive.
e. The Beck Hopelessness Scale asks questions about my view of the future.
f. The Posttraumatic Stress Diagnosis Scale evaluates the presence and severity o f symptoms
often experienced after a trauma.
g. The Mississippi Scale measures the level or severity o f symptoms sometimes related to combat
experience.
h. The Modified Concerns about Change Scale evaluates the possible consequences a person
feels he may experience due to changing behaviors.
i. The Quality o f Life Scale includes questions regarding how happy a person is with his life.
j. Client Satisfaction Questionnaire evaluates how happy a person is with the treatment he has
received.
I will be asked to complete these questionnaires at the beginning and end o f my admission into the
R-track. I will also be asked to come back 1 and 2 months after my discharge date to complete some or
all o f the questionnaires again.
3. Procedures that may result in discomfort or inconvenience:
I will be asked to complete the questionnaires, which will take up to 2-3 hours and ask persoral
questions that may cause some discomfort for me. 1will be asked to do this once before starting the Rtrack and three times after finishing the R-track.
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4. Expected risks of the study:
One potential risk o f my participation in this project is that I may become emotionally upset while
completing the questionnaires. However, trained staff are prepared to assist me or terminate the
assessment session and provide, or refer me for, crisis counseling should I become significantly upset
The staff are prepared to make a referral if I need further counseling. If an accidental injury occurs,
appropriate emergency measures will be taken; however, no compensation or additional treatment will be
made available to me by Western Michigan University except as otherwise stated in this consent form.
5. Expected benefits of the study:
Although I may not personally benefit from participation in this study, the knowledge gained from
this research may help others who have been traumatized and experience depression. Once the study is
completed, I may receive a general summary o f the results of the project if I so wish.
6. Other treatment available:
I will receive inpatient treatment on ward 12 and in the outpatient PTSD clinic for PTSD-related
problems. I will be responsible for the cost o f therapy if I choose to pursue it outside the BCVAMC.

7. Use o f the research results:
All the information collected from me is confidential, with the exception o f information regarding
intent to harm oneself or another person or reports of abuse or neglect to children or vulnerable adults.
These specific incidents, as well as any other information requiring disclosure in order to protect others
from serious harm or the potential for serious harm, require disclosure to the appropriate person and/or
authorities. Information relevant to my continued treatment at this hospital may be included in my
hospital file, which is guarded from access by anyone outside the VA system and is only available to
authorized VA personnel. All other data will be coded and will not contain identifying information. A
master list will be kept which includes names and respective codes. Once the data are collected and
analyzed, the master list will be destroyed. All forms not included in my medical chart will be retained
for a minimum of five years in a locked file at the BCVAMC. The results of this study may be published,
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but my identity and records will remain confidential. All results used in publication will be reported as
group data with no individual identification. My individual results will not be revealed unless required by law.
8. Special circumstances:
Since I am a veteran-subject, I will normally not be required to pay for services received as a
subject in a VA research program, but may be subject to copayment if I fall within the “discretionary
work load” category and meet the means test 1 will receive medical care and treatment for injuries
suffered as a result o f participation in a VA research program in accordance with Federal law. My
participation in this research project and any information documented in my medical records as a result
o f my participation in this research project may not necessarily have a beneficial effect on any claim for
monetary compensation from the Government nor does my participation in this research project
necessarily entitle me to monetary compensation for any such claim. If I have any questions or concerns
regarding my consent to participate in the present study, I may contact the Chairperson o f the BCVAMC
Subcommittee on Human Studies, Cheryl Thrum at (616) 966-5600, extension 3551. I may also contact
the Western Michigan University Chair, Human Subjects Institutional Review Board (387-8293) or the
Vice President for Research (387-8298) if questions or problems arise during the course o f the study.
9. Research subjects’ rights:
My signature below indicates that I have read and/or had read to me all o f the above.
____________________ has explained the study to me and answered all o f my questions. I have been
told o f the risks or discomforts and possible benefits o f the study. I have been told about treatments
available to me.
I do not have to take part in this study, and my refusal to participate will involve no penalty or loss
o f rights to which 1am entitled. I may refuse to participate or quit at any time during the study without
prejudice, penalty, or risk of any loss of service I would otherwise have and without penalty or loss o f VA
or other benefits to which I am entitled. The results o f this study may be published, but my records will
not be revealed unless required by law. If I have any questions or concerns about this study, I may call
the BCVAMC and contact Dr. William Bloem at (616)966-5600 extension 5344 or Western Michigan
University and contact Dr. C. Richard Spates at (616)387-4329. I can also call Theodore Wright at
(616)323-8307.
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In case there are medical problems or questions, I have been told I can call Dr. Bioem at extension
5344 during the day or contact him through extension 0 after hours. If any medical problems occur in
connection with this study, the VA will provide emergency care. My rights as a research subject have
been explained to me and I voluntarily consent to participate in this study. How and why this study is
being completed has been explained to me. I will receive a signed copy of this consent form to keep in
my personal records. Signature of Subject’s Representative is only required if subject is not competent
This consent document has been approved for use for one year by the Western Michigan
University Human Subjects Institutional Review Board (HSIRB) as indicated by the stamped date and
signature of the board chair in the upper right comer of each page. Participants should not sign this
document if the comer does not show a stamped date and signature.

Subject’s Signature -

Date

Signature of Subject’s Representative

Subject’s Representative

Signature of Witness

Witness (print)

Signature of Investigator
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DEMOGRAPHIC QUESTIONNAIRE
Please answer the following questions.

Age___________
Race

(please circle appropriate answer)
African American
Native American
Hispanic
Pacific Islander
Asian American
Alaska Native
Caucasian
Intemational/Non-U.S. Resident (please specify nationality)_______________
Multiracial (please specify)__________________________
Other: (please specify)____________________________

Marital Status
Single
Divorced

(please circle appropriate answer)
Married
Separated
Engaged
Living With Partner

Do yOU have children?

(Please circle appropriate answer)
Yes

No

Education

(please indicate the last year of school completed)_______________

Years of military service
Branch of service
Marines
Air Force

- 19

to 19_____

(please circle appropriate answer)
Army
Navy
Other (Please identify)______________

Military Operating Specialty
(please list your MOS upon discharge)_____________________________

Highest Rank Achieved________________________
Months in a combat situation___________________
Were you injured in combat? (please circle appropriate answer)
Yes

No
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Demographic Questionnaire—Continued

Arc yOU service connected?
Yes

(please circle appropriate answer)
If yes, what is your percentage?________________________
What are your service connected for?____________________

No

Are you seeking service connection for PTSD-related
disability? (please circle appropriate answer)
Yes

No

If you are service connected for PTSD, are you currently
seeking to increase your percentage of service connection?
(please circle appropriate answer)
Yes
If yes, from________ %to __________ %
No

Have you received INPATIENT treatment for PTSD in the
past? (please circle appropriate answer)
Yes
No

If yes, how many times have you been treated as an inpatient?______

Have you received OUTPATIENT treatment for PTSD in
the past? (please circle appropriate answer)
Yes
No

If yes, for how long were you seen as an outpatient?_____________

Have you received INPATIENT treatment for depression
in the past? (please circle appropriate answer)
Yes
No

If yes, how many times have you been treated as an inpatient?______

Have you received OUTPATIENT treatment for
depression in the past? (please circle appropriate answer)
Yes
No

If yes, for how long were you seen as an outpatient?_____________
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Demographic Questionnaire—Continued

Have you taken medication for PTSD or depression in the
past? (please circle appropriate answer)
Yes

Please check for PTSD
and/or for depression____
For how long? _____________________ months.

No

How many hours does it take you to get to the VA when
yOU drive? (please circle appropriate answer)
Less than half an hour

Less than 1 hour

Less than 3 hours

Over 3 hours

Less than 2 hours
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BATTLE CREEK, MICHIGAN VA MEDICAL CENTER
SPECIALIZED INPATIENT PTSD UNIT RESIDENTIAL PROGRAM

REHABILITATION (R) TRACK
Sunday

1:00 -3 :3 0
TOURNAMENTS
BLDO 6

i

Monday

Tuesday

Wednesday

Thursday

1:00-1:30
COMMUNITY MEETING
RM. 107

8:00 - 8:30
NUTRITION A
HEALTH
RM. 107
Jane Fraley, RD

8:00 - 9:00
SLEEP ENHANCEMENT
RM 107
Sue Yerge, RNC

8 :0 0 -8 :3 0
WARD OOVERNMENT
RM 107
(elected offloe cannot be
turned down)

9 :0 0 -1 0 :1 3
OROUP THERAPY
RM. 119B
Paydiology Staff
Nuning Staff
10:30-11:30
PHYSICAL
CONDITIONING
BLDO 134
PMARS Staff
1:0 0 -2 :0 0
MEANING A VALUES
RM. 107
Chaplain
Paydiology Servioe

8 :3 0 -1 0 :3 0
CUNIC
APPOINTMENTS AS
SCHEDULED

8:30-8:43 (one time only)
ORIENTATION CLASS
Jick lleely, NA
9:0 0-1 0 :1 3
OROUPTHERAPY
RM. 1I9B
Paydiology Staff
N u n tn i Staff
10:30-11:30
PHYSICAL
CONDmONINO
BLDO. 134
O R TAI CHI RM. 107
1:0 0-3 .0 0
STRESS MANAGEMENT
RM. 107
Dhamt Baines, PhD
Jo An Knox, RN, BSN

1 0:30-11:13
LEISURE EDUCATION
RM. 107
Oery Decker, RT
1 :0 0 -2 :0 0
ANGER
MANAGEMENT
RM. 107
Ike Potter, Chaplain

3 :3 0 - 3:00
OPENOYM
BLDO. 134

2 :3 0 -3 :3 0
MEDICATION A YOU
RM. 107
Nuning Staff
Fhaimacy

2 :3 0 -3 :3 0
SUBSTANCE
AWARENESS
R M 107
William Bioem, PhD
Tom Hicks, MSW

(OTHER
ACTIVITIES AS
SCHEDULED.
ACTIVITIES
SUBJECT TO
CHANOE1
WARDTOUNEYS
AS SCHEDULED
BYWD. 13
RECREATION
OFFICER. CHECK
BULLETIN BOARD
IN RM. 107

3 :3 0 -6 :3 0
TRAUMA RECOVERY
OROUP
BLDO. I0/RM. 123
Dhamm Balnea, PltD
-B Y REFERRAL3 :3 0 -8 :3 0
WOOD SCULPTUR1NO
BLDO. <
Oaty Docker, RT
•BY REFERRAL
(OPTIONAL)

3 :3 0 -8 :3 0
CRAFT CUNIC
BLDO. 6
(OPTIONAL)

8 :0 0 -9 :0 0
AA MEETINO
BLDO. 13-2
(OPTIONAL)

2 :3 0 -3 :3 0
RELATIONSHIPS A
ASSERTIVE
COMMUNICATION
RM. 107
Sotet Dricatnga, FhD
Judy Walldorff. RNC
3 :3 0 -6 :3 0
WOOD SCULPTURING
BLDO. 6
(OPTIONAL)

10:30-11:13
LEISURE EDUCATION
RM. 107
Oary Decker, RT
1:0 0 -2 :0 0
UFESTYLE A
HEALTHY BEHAVIORS
RM 107
Nursing Staff

Friday

9 :0 0 -1 0 :1 3
OROUP THERAPY
RM. I19B
Paydiology Staff
N unina Staff
10:30-11:30
PHYSICAL
CONDITIONING
BLDO. 134
PMARS Staff
1:0 0 -4 :3 0
INDIVIDUAL
THERAPY WITH
PRIMARY
THERAPIST A
PRIMARY NURSE

Saturday

1:0 0 -3 :3 0
Adivkiesas
Scheduled. Please
Check Aaivitiea
Sheet an Bulletin
Board in RM 107
BLDO. 6

2 :3 0 -3 :3 0
CHOICES
Please See Clip-Board At
Nuning Station For
Today's Choioea. YOU
MUST SION UP FOR
ONE CHOICE.

•

7 :0 0 -9 :0 0
ACTIVITIES AS
SCHEDULED.
ACTIVITIES
SUBJECT TO
CHANOE.
BLDO. 6
8:00 - 9:00
NA MEETINO
BLDO. 13-2
(OPTIONAL)

8:00 - 9:00
AA MEETINO
BLDO. 13-2
(OPTIONAL)
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BATTLE CREEK, MICHIGAN VA MEDICAL CENTER
SPECIALIZED INPATIENT PTSD UNIT RESIDENTIAL PROGRAM

REHABILITATION (R) TRACK
Sunday

1:00-1:30
TOURNAMENTS
BIJX3.6

Monday

Tuesday

Wednesday

Thursday

8.00 • 8:30
COMMUNITY MEETINO
RM 107

8:00 - 8:30
NUTRITION &
HEALTH
R M 107
Jane Fraley, RD
8:30 - 10:00
BA OROUP
RM. 103

8:00 - 9:00
SLEEP ENHANCEMENT
RM. 107
Sue Ycrge, RNC

8:00 - 8:30
WARD GOVERNMENT
RM 107
(d eaed ofTloe carru e be
turned down)
8.30 - 10:00
BA OROUP
RM. 103
10:00-10:30
CLINIC
APPOINTMENTS AS
SCHEDULED

8:30.8 45 (one lime oily)
ORIENTATION CLASS
Jack Heely, NA
9 :0 0 -1 0 :1 3
OROUP THERAPY
RM 1I9B
Psychology SUIT
Nuning SUIT
10:30-11:30
PHYSICAL
CONDITIONING
BLDO. 134
O R TA1 CHIRM. 107
1 :0 0 -3 :0 0
STRESS MANAGEMENT
RM 107
D hum Bainca, PhD
Jo An Kno«, RN, BSN

1 0:30-11:13
LEISURE EDUCATION
R M 107
Oaiy Decker, RT
1 :0 0 -3 :0 0
ANOER
MANAOEMENT
RM. 107
Ike Potter, Chaplain

3 :3 0 -3 :0 0
OPENOYM
B1J30. 134

3:3 0 -3 :3 0
MEDICATION A YOU
RM 107
Nuning Staff
Pharmacy

3 :3 0 -3 :3 0
SUBSTANCE
AWARENESS
RM 107
William Bioem, PhD
Tom llicka, MSW

(OTHER
ACTIVITIES AS
SCHEDULED.
ACTIVITIES
SUBJECT TO
CHANOE)
WARDTOUNEYS
AS SCHEDULED
BY WD. 13
RECREATION
OFFICER. CHECK
BULLETIN BOARD
IN RM 107

3 :3 0 -6 :3 0
TRAUMA RECOVERY
OROUP
BLDO. 10/RM. 133
Dhamm B a k u , PhD
-B Y REFERRAL.
3:30 - 8:30
WOOD SCULPTURING
BLDO. 6
Oaiy Docker, RT
■BY REFERRAL(OPTIONAL)

3 :3 0 -8 :3 0
CRAFT CLINIC
BLDO. 6
(OPTIONAL)

8:00 - 9:00
AA MEETINO
BLDO 13-3
(OPTTONAL1

9 :0 0 -1 0 :1 3
OROUP THERAPY
R M II9 B
Paydiology SUIT
Nuning SulT
10:30-11:30
PHYSICAL
CONDITIONING
BLDO. 134
PMARS SUIT
1:0 0 -3 :0 0
MEANINO A VALUES
RM 107
Chaplain
Paychulogy Service

3 :3 0 -3 :3 0
RELATIONSHIPS A
ASSERTIVE
COMMUNICATION
RM 107
Soon Drieeoiga, PhD
Judy Walldorff. RNC
3 :3 0 -6 :3 0
WOODSCULPTURINO
BLDO. 6
(OPTIONAL)

10:30-11:13
LEISURE EDUCATION
R M 107
Oary Decker, RT
1:0 0 -3 :0 0
LIFESTYLE A
HEALTHY BEHAVIORS
RM 107
Nuning SulT

Friday

9 :0 0 -1 0 :1 3
GROUP THERAPY
RM. II9 B
Paychology SulT
N u n in t Suer
10:30-11:30
PHYSICAL
CONDITIONING
BLDO. 134
PMARS S u ff
1:0 0 -4 :3 0
INDIVIDUAL
THERAPY WITH
PRIMARY
THERAPIST A
PRIMARY NURSE

Saturday

1 :0 0 -3 :3 0
A c tiv e lea at

Scheduled. Pleaae
Check Acaivkiea
Sheet on Bulletin
Board in RM 107
BLDO. 6

3 :3 0 -3 :3 0
CHOICES
Pleaae See Clip.Board At
N uning Station For
Today'a Choioea. YOU
MUST SION UP FOR
ONE CHOICE.

7 :0 0 -9 :0 0
ACTIVITIES AS
SCHEDULED.
ACTIVITIES
SUBJECT TO
CHANOE.
BLDO. 6
8 :0 0 -9 :0 0
NA MEETINO
BLDO. 13-3
(OPTIONAL)

8:00 - 9:00
AA MEETINO
BLDO 13-3
(OPTIONAL)

to
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Behavioral Activation Group Format
1. Opening
•
•

Greeting & Any Questions
Format of Meeting

2. Review Homework
•
•
•

Hand in Homework Checklist
Review Homework with Group
Questions or Difficulties

3. Psychoeducational Topic
•

Present Topic

4. Group Discussion o f Topic
•

Facilitate Discussion

5. Group Discussion of Individual Behaviors
•

Facilitate Discussion

6. Closing
Homework
Questions & Comments
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Behavioral Activation Group Outline
Session 1
1. Group Introduction
2. Review Group Format
a. Ground Rules
b. Therapist as a Personal Trainer
3. Read Self-Help Manual as Group
4. Begin Functional Analysis with Group
a. Identifying Problematic Precipitating Factors and Current Coping
Techniques
5. Discuss New/Different Coping Options
6. Closing
a. Homework
Session 2
1. Opening
a. Discuss Agenda
2. Homework Review
3. Present Topics
a. Self-Defeating Behavior, Aversive Environments, Assertiveness,
and Communication Skills
4. Discuss Topics
5. Identify Individual Self-Defeating Behaviors/Bad Environments
a. Develop Options for These Behaviors/Environments
6. Closing
a. Homework
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Behavioral Activation Group Outline—Continued
Sessions 3 -7
1. Opening
a. Discuss Agenda
2. Homework Review
3. Two Psychoeducational Topics Presented in Each Session
a. Activity Mastery and Pleasure, Activity Monitoring, Active Versus
Passive Approach to Problems, Graded Task Assignment,
Behavioral Stopping, Alternative Behaviors and Outcomes,
Self-Reinforcement, Distraction from Problems or Unpleasant
Events, Role-Playing Social Situations, and Mental Rehearsal of
Activities
4. Discuss Topic
5. Identify Individual Behaviors Relevant to Topic
a. Develop New Options for These Behaviors
6. Closing
a. Homework
Session 8
1. Opening
a. Discuss Agenda
2. Homework Review
3. Review Treatment Topics
a. Self-Defeating Behavior, Aversive Environments, Assertiveness,
Activity Mastery and Pleasure, Activity Monitoring, Active Versus
Passive Approach to Problems, Graded Task Assignment,
Behavioral Stopping, Alternative Behaviors and Outcomes, SelfReinforcement, Distraction from Problems or Unpleasant Events,
Role-Playing Social Situations, and Mental Rehearsal of Activities
4. Discuss Individual Progress
5. Identify Skills Learned to be Used for Relapse Prevention
6. Closing
a. Goodbyes
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Therapist Rating of Homework Completion Form
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THERAPIST RATING OF HOMEWORK COMPLETION
Patient’s Last 4: _____________

Date:_______

Therapist’s Name: ________________________
Homework from Session # (in which session was the homework assigned):
Please use the following scale to rate how completely you believe the client did the
homework assignment. Circle the most appropriate number.
0 = Nothing done.

The subject did not hand any written responses and did not
indicate he tried the homework.

1 = Very little done. The subject handed in a sheet with minimal written product and
did not indicate that he tried. OR The subject had no written
product, but stated that he tried (or did) the assignment.
2 = Made an effort. The subject handed in some written product that is adequate for
the assignment given.
3 = Notable effort. The subject handed in written product that shows good
understanding of the information presented.
4 = Excellent effort. The subject handed in written product that is COMPLETELY
done. Nothing more could have been done with this assignment.
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THERAPIST SELF-RATING SHEET
SESSION 1
Therapist’s Name: ____________________ Date: ______________________
Please rate how well you did each of these tasks for this session on a scale with:
0 = Horrible job or completely forgot about it
1 = Bad job or barely touched on it
2 = Average job or covered it adequately
3 = Good job or covered most of the material
4 = Excellent job or covered every last bit of information
I introduced myself and had group members introduce themselves.
I discussed the format for the group sessions
I reviewed the ground rules and got feedback from group members
I explained how the therapist acts like a “personal trainer”
I reviewed the agenda for the meeting
I got the group to read the Self-help Manual
I presented the concept of functional analysis
I got the group to give examples of problems with which they are struggling
I covered new/different coping skills
I got the group to participate in discussion of new/different coping skills
I reviewed the homework assignments and answered questions
OVERALL, I connected with the group and felt they were interested in the
group
OVERALL, I felt the group generally understood the information covered in
the group
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THERAPIST SELF-RATING SHEET
SESSION 2
Therapist’s Name: ____________________ Date:_______________________
Please rate how well you did each of these tasks for this session on a scale with:
0 = Horrible job or completely forgot about it
1 = Bad job or barely touched on it
2 = Average job or covered it adequately
3 = Good job or covered most o f the material
4 = Excellent job or covered every last bit of information
I greeted the group and asked for questions.
I briefly reviewed the ground rules
I reviewed the agenda for the meeting
I collected homework assignments and discussed their homework with them
I GAVE THE BDI-H and collected them
I discussed assertive, passive, aggressive, and passive-aggressive behaviors
with the group
I discussed ingredients to assertive communication
I got the group to give examples of problems they have had with being
assertive
I covered self-defeating behaviors
I got the group to participate in discussion o f self-defeating behaviors
I covered aversive environments
I got the group to participate in discussion of aversive environments
I gave the next homework assignment
I reviewed the Pleasurable Activities Scales and made copies for the members
OVERALL, I connected with the group and felt they were interested in the
group
OVERALL, I felt the group generally understood the information covered in
the group
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THERAPIST SELF-RATING SHEET
SESSION 3
Therapist’s Name: ____________________Date: ______________________
Please rate how well you did each of these tasks for this session on a scale with:
0 = Horrible job or completely forgot about it
1 = Bad job or barely touched on it
2 = Average job or covered it adequately
3 = Good job or covered most of the material
4 = Excellent job or covered every last bit of information
I picked out the appropriate inserts and gave group members handouts on
the topics chosen for the group
I greeted the group and asked for questions
I gave members a copy of their Pleasurable Activities Scale for future
reference
I briefly remind group of the ground rules
I reviewed the agenda for the meeting
I collected homework assignments and discussed their homework with them
I discussed (Activity Pleasure & Mastery) O R _______________________
I assessed understanding & got the group to discuss the topic and give
personal examples/ideas.
I discussed (Activity Monitoring) O R ______________________________
I assessed understanding & got the group to discuss the topic and give
personal examples/ideas.
I gave the next homework assignment
OVERALL, I connected with group members and felt they were interested in
the group
OVERALL, I felt the group generally understood the information covered in
the group
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THERAPIST SELF-RATING SHEET
SESSION 4
Therapist’s Name: ____________________Date:_________
Please rate how well you did each of these tasks for this session on a scale with:
0 = Horrible job or completely forgot about it
1 = Bad job or barely touched on it
2 = Average job or covered it adequately
3 = Good job or covered most of the material
4 = Excellent job or covered every last bit of information
I picked out the appropriate inserts and gave group members handouts on
the topics chosen for the group
I greeted the group and asked for questions
I reviewed the agenda for the meeting
I GAVE THE BDI-H and collected them
I collected homework assignments and discussed their homework with them
I discussed (Active Vs. Passive Approaches to Problems) O R _____________
I assessed understanding & got the group to discuss the topic and give
personal examples/ideas.
I discussed (Graded Task Assignment) O R _____________________
I assessed understanding & got the group to discuss the topic and give
personal examples/ideas.
I was able to generate discussion and sharing in the group
I explained the next homework assignment and answered questions
OVERALL, I connected with group members and felt they were interested in
the group
OVERALL, I felt the group generally understood the information covered in
the group
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THERAPIST SELF-RATING SHEET
SESSION 5
Therapist’s Name: ____________________ Date: ______________________
Please rate how well you did each of these tasks for this session on a scale with:
0 = Horrible job or completely forgot about it
1 = Bad job or barely touched on it
2 = Average job or covered it adequately
3 = Good job or covered most of the material
4 = Excellent job or covered every last bit o f information
I picked out the appropriate inserts and gave group members handouts on
the topics chosen for the group
I greeted the group and asked for questions
I reviewed the agenda for the meeting
I collected homework assignments and discussed their homework with them
I discussed (Behavioral Stopping) O R ______________________________
I assessed understanding & got the group to discuss the topic and give
personal examples/ideas.
I discussed (Alternative Behaviors and Outcomes) O R _________________
I assessed understanding & got the group to discuss the topic and give
personal examples/ideas.
I was able to generate discussion and sharing in the group
I explained the next homework assignment and answered questions
OVERALL, I connected with group members and felt they were interested in
the group
OVERALL, I felt the group generally understood the information covered in
the group
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THERAPIST SELF-RATING SHEET
SESSION 6
Therapist’s Name: ____________________Date: _____________________
Please rate how well you did each of these tasks for this session on a scale with:
0 = Horrible job or completely forgot about it
1 = Bad job or barely touched on it
2 = Average job or covered it adequately
3 = Good job or covered most of the material
4 = Excellent job or covered every last bit of information
I picked out the appropriate inserts and gave group members handouts on
the topics chosen for the group
I greeted the group and asked for questions
I reviewed the agenda for the meeting
I GAVE THE BDI-n and collected them
I collected homework assignments and discussed their homework with them
I discussed (Giving Yourself Rewards) O R __________________________
I assessed understanding & got the group to discuss the topic and give
personal examples/ideas.
I discussed (Distraction from Problems or Events) O R ________________
I assessed understanding & got the group to discuss the topic and give
personal examples/ideas.
I was able to generate discussion and sharing in the group
I explained the next homework assignment and answered questions
OVERALL, I connected with group members and felt they were interested in
the group
OVERALL, I felt the group generally understood the information covered in
the group
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THERAPIST SELF-RATING SHEET
SESSION 7
Therapist’s Name: ____________________ Date: _____________________
Please rate how well you did each of these tasks for this session on a scale with:
0 = Horrible job or completely forgot about it
1 = Bad job or barely touched on it
2 = Average job or covered it adequately
3 = Good job or covered most of the material
4 = Excellent job or covered every last bit of information
I picked out the appropriate inserts and gave group members handouts on
the topics chosen for the group
I greeted the group and asked for questions
I reviewed the agenda for the meeting
I collected homework assignments and discussed their homework with them
I discussed (Behavioral Rehearsal) O R _____________________________
I assessed understanding & got the group to discuss the topic and give
personal examples/ideas.
I discussed (Mental Rehearsal of Activities) O R ______________________
I assessed understanding & got the group to discuss the topic and give
personal examples/ideas.
I was able to generate discussion and sharing in the group
I explained the next homework assignment and answered questions
OVERALL, I connected with group members and felt they were interested in
the group
OVERALL, I felt the group generally understood the information covered in
the group
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THERAPIST SELF-RATING SHEET
SESSION 8
Therapist’s Name: ___________________ Date: ______________________
Please rate how well you did each o f these tasks for this session on a scale with:
0 = Horrible job or completely forgot about it
1 = Bad job or barely touched on it
2 = Average job or covered it adequately
3 = Good job or covered most of the material
4 = Excellent job or covered every last bit of information
I greeted the group and asked for questions
I reviewed the agenda for the meeting
I GAVE THE BDI-H and collected them
I collected homework assignments and discussed their homework with them
I reviewed treatment topics from the prior 7 groups
I got feedback from group members regarding the most/least helpful topics
I discussed each group member’s progress in the group
I gave praise and encouragement to group members for their effort
I discussed relapse prevention/future problem solving with the group
I encouraged group members to come back for scheduled assessment
appointments after 1 and 2 months
I answered questions, provided closure to the group, and said goodbye

I GAVE THE Client Satisfaction Questionnaire (CSQ) and collected them
OVERALL, I connected with group members and felt they were interested in
the group
OVERALL, I felt the group generally understood the information covered in
the group
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